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1 Summary 
Our skin is constantly exposed to a large number of pathogens while at the same 
time undergoing selective colonization by commensal microorganisms such as 
Coagulase-negative Staphylococci. Staphylococcus aureus, however, is a facultative 
pathogen that is usually absent from healthy skin but frequently colonizes the 
inflamed skin of atopic dermatitis (AD) patients where it further promotes 
inflammation. Thereby, increasing S. aureus colonization was shown to correlate with 
a loss of microbiome diversity indicating a role for skin commensals to shape 
pathogen colonization. Keratinocytes, as the most abundant and outermost cell type 
in the epidermis, need to discriminate commensals from pathogens and orchestrate 
subsequent immune reactions in response to colonizing microbes. However, the 
mechanisms how individual commensals cooperate with keratinocytes and the 
immune system of the skin to prevent pathogen colonization are barely understood. 
Therefore, this work aimed at investigating the functional effects of two skin 
commensals, S. epidermidis and S. lugdunensis, on S. aureus skin colonization. 
Using an in vitro adhesion and invasion assay with primary human keratinocytes and 
an epicutaneous mouse skin colonization model we show that pretreatment with S. 
epidermidis or its secreted factors significantly reduces S. aureus skin colonization. 
However, in this work we also demonstrate that this protection is dependent on the 
integrity of the epithelial barrier and is completely lost during skin inflammation. 
Using the same models, we further demonstrate that the S. lugdunensis-derived 
cyclic peptide antibiotic, lugdunin, which was previously shown to inhibit S. aureus 
epithelial colonization, induces a similar protective effect in human keratinocytes and 
mouse skin. Additionally, lugdunin can amplify the S. epidermidis-induced effect. 
Further analysis revealed that, beyond its bactericidal activity, lugdunin also 
possesses TLR/MyD88-dependent immune-modulatory activities which lead to 
expression and release of LL-37 and CXCL8/MIP-2 in human keratinocytes and 
mouse skin as well as to the recruitment of monocytes and neutrophils in mouse skin. 
Ultimately, synergistic antimicrobial activity in combination with skin-derived AMPs 
indicates that lugdunin is a multi-functional peptide providing host protection against 
S. aureus by multiple mechanisms. 
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Since S. aureus frequently colonizes the inflamed skin of AD patients, this work 
also aimed at understanding how inflammation contributes to the initial skin 
colonization event with S. aureus. We found that recruited neutrophils in response to 
tape-stripping enhance S. aureus colonization. These findings were confirmed using 
an in vitro co-culture model with keratinocytes and neutrophils. Further analysis of the 
mechanism demonstrated that neutrophil extracellular traps (NETs) influence 
keratinocytes in a way that favors S. aureus colonization. Finally, we show that S. 
epidermidis can reduce neutrophil recruitment induced by S. aureus, which might 
partly explain how microbiota contribute to pathogen skin protection during 
homeostasis. At the same time this work suggests that during skin inflammation the 
release of NETs by infiltrating neutrophils superimposes the microbiota-mediated skin 
protection and might thus result in enhanced S. aureus colonization. 
In conclusion, this work describes how two members of our skin microbiota, S. 
epidermidis and S. lugdunensis, can prevent S. aureus skin colonization. Thus, it 
delineates new ways how commensals protect our skin from pathogens. In addition, 
the work presented here also illustrates that S. epidermidis contributes to increased 
S. aureus colonization during skin inflammation and that the recruitment of immune 
cells can have conflicting effects. Consequently, the signals of the skin microbiome 
need to be interpreted in the corresponding microenvironment. 
Zusammenfassung 
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2 Zusammenfassung 
Unsere Haut ist einer Vielzahl von Krankheitserregern permanent ausgesetzt und 
wird gleichzeitig mit ausgewählten kommensalen Mikroorganismen wie den 
Coagulase-negativen Staphylokokken besiedelt. Staphylococcus aureus ist im 
Gegensatz dazu ein fakultativ-pathogener Erreger, der gesunde Haut normalerweise 
nicht kolonisiert. Auf entzündeter Haut von Atopikern ist er jedoch sehr häufig zu 
finden, wo er die Entzündung weiter stimuliert. Interessanterweise geht die erhöhte 
S. aureus Kolonisierung mit einem Verlust der Mikrobiom-Diversität einher. Dies 
deutet darauf hin, dass Kommensale die Hautkolonisierung von Krankheitserregern 
weitgehend beeinflussen. Keratinozyten, die vorwiegenden Zellen in der Epidermis, 
müssen in der Lage sein, Kommensale von Krankheitserregern zu unterscheiden um 
nachfolgende Immunreaktionen entsprechend zu koordinieren. Die Mechanismen, 
wie einzelne Kommensale zusammen mit Keratinozyten und dem Immunsystem die 
Haut vor Krankheitserregern schützen, sind jedoch bisher weitestgehend unerforscht. 
Ein Ziel dieser Forschungsarbeit war es daher, die funktionellen Auswirkungen 
von zwei Kommensalen, S. epidermidis und S. lugdunensis, auf die S. aureus 
Kolonisierung der Haut zu untersuchen. Mit einem in vitro Adhäsions- und 
Invasionsassay mit primären humanen Keratinozyten und einem epikutanen Modell 
der Maushautkolonisierung zeigen wir, dass eine Vorbehandlung mit S. epidermidis 
oder mit dessen sekretierten Faktoren die S. aureus Kolonisierung signifikant 
reduziert. Wir stellen allerdings auch dar, dass dieser Schutz von der Integrität der 
Epithelbarriere abhängt und während einer Hautentzündung vollständig verloren 
geht. 
Mit den gleichen Modellen zeigen wir außerdem, dass das zyklische Peptid-
Antibiotikum Lugdunin, welches von S. lugdunensis produziert wird und für welches 
zuvor eine bakterizide Wirkung auf S. aureus gezeigt wurde, eine ähnliche 
Schutzwirkung in humanen Keratinozyten und in Maushaut hervorruft. Weitere 
Analysen ergaben, dass Lugdunin über seine bakterizide Wirkung hinaus, auch 
TLR/MyD88-abhängige immunmodulatorische Eigenschaften besitzt, die sowohl zur 
Expression und Freisetzung von LL-37 und CXCL8/MIP-2 in menschlichen 
Keratinozyten und in der Maushaut führen, als auch zur Rekrutierung von Monozyten 
und Neutrophilen in die Maushaut. Zusätzlich besitzt Lugdunin in Kombination mit 
Zusammenfassung 
 12 
humanen antimikrobiellen Peptiden aus der Haut eine synergistische bakterizide 
Wirkung gegen S. aureus. Daraus ergibt sich, dass Lugdunin ein multifunktionales 
Peptid ist, das uns durch eine Vielzahl von Mechanismen vor S. aureus schützen 
kann. 
Ein weiteres Ziel dieser Arbeit war es zu verstehen, wie eine Entzündung zur 
erstmaligen Besiedelung der Haut mit S. aureus beiträgt. Dabei fanden wir heraus, 
dass durch entzündungsauslösendes Tape-stripping Neutrophile rekrutiert werden, 
die die S. aureus Kolonisierung fördern. Diese Ergebnisse konnten mit einem in vitro 
Co-Kulturmodell mit Keratinozyten und Neutrophilen bestätigt werden. Weitere 
mechanistische Analysen zeigten, dass neutrophile extrazelluläre Fallen (NETs) im 
Co-Kultursystem freigesetzt werden und Keratinozyten so beeinflussen, dass die S. 
aureus Kolonisierung begünstigt wird. Interessanterweise konnte diese verstärkte 
Bildung von NETs in vitro als auch die Rekrutierung von Neutrophilen in vivo durch 
eine Vorbehandlung mit S. epidermidis reduziert werden. Dies erklärt zumindest 
teilweise, wie S. epidermidis zum Schutz vor S. aureus beiträgt. Gleichzeitig deutet 
diese Arbeit darauf hin, dass bei Hautentzündungen NETs von infiltrierenden 
Neutrophilen freigesetzt werden, wodurch es zu einer Überlagerung des durch S. 
epidermidis vermittelten Hautschutzes und somit zu einer erhöhten S. aureus 
Kolonisierung kommt. 
Zusammenfassend zeigt diese Arbeit, wie zwei Bestandteile unserer Hautflora, S. 
epidermidis und S. lugdunensis, eine S. aureus Kolonisierung verhindern können und 
führt somit weitere Wege auf, wie Kommensale unsere Haut vor Pathogenen 
schützen. Allerdings wird auch dargestellt, dass S. epidermidis während einer 
Entzündung zur erhöhten S. aureus Kolonisierung beiträgt und dass die Rekrutierung 
von Immunzellen gegensätzliche Auswirkungen haben kann. Folglich müssen die 
Signale des Hautmikrobioms in Abhängigkeit der entsprechenden Mikroumgebung 
interpretiert werden.  
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5 Introduction 
5.1 Skin immunity 
The primary function of our skin is to serve as a physical barrier that protects our 
body from environmental insults while at the same time it prevents water loss. From 
the moment of birth, our skin, as the outermost layer to the environment, is also 
constantly exposed to a large set of different microbes including potential pathogens. 
Therefore, it must be actively involved in immune defense that allows commensal 
microbes to colonize while at the same time pathogenic bacteria such as 
Staphylococcus aureus are effectively prevented from colonizing. This is achieved 
mainly by the keratinocytes, the major cell type of the epidermis, which sense 
colonizing microbes and coordinate subsequent immune responses in the skin. 
Expression of antimicrobial peptides (AMPs) by keratinocytes provides a first level of 
defense against invading pathogens. Moreover, using different pattern recognition 
receptors (PRRs) keratinocytes can detect and discriminate commensals from 
pathogens and initiate an adequate response by secreting cytokines and chemokines 
which subsequently recruit and activate immune cells (Accepted Manuscript I 
(Bitschar et al., 2017)). In addition to keratinocytes, different immune cell subsets 
reside throughout the skin and contribute to skin homeostasis and immunity 
(Pasparakis et al., 2014). 
Structurally the skin is composed of two distinct layers: the epidermis and the 
dermis (Figure 1). The epidermis forms the outermost barrier to the environment and 
is composed of layers of differentiated keratinocytes. The basal layer is the stratum 
basale which mainly consists of undifferentiated, dividing keratinocytes, that are 
constantly renewing the epidermis. Within 4 weeks of differentiation, keratinocytes 
move towards the outer layers, first forming the stratum spinosum followed by the 
stratum granulosum and finally the stratum corneum building the outermost layer 
which consists of terminally differentiated, dead and cornified keratinocytes that are 
chemically crosslinked and continuously shed from the skin surface (Fuchs and 
Raghavan, 2002; Segre, 2006). These cornified cells are surrounded by lipids which 
provide a physical and water-retaining barrier of the skin (Candi et al., 2005). In 
addition to keratinocytes, melanocytes and Langerhans cells are dispersed 
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throughout the epidermis. While the former contribute to UV radiation protection, the 
latter are antigen-presenting cells involved in cutaneous immune defense. 
Below the epidermis, the dermis harbors fibroblasts which produce extracellular 
matrix proteins such as collagen and elastin in order to provide structural support for 
the skin. Additionally, the dermis anchors blood and lymphatic vessels as well as 
different appendages such as sweat and sebaceous glands or hair follicles. It also 
harbors a multitude of different resident as well as patrolling immune cells that 
contribute to tissue homeostasis and skin immunity. Underneath the dermis lies the 
hypodermis which constitutes an important depot of fat and is involved in 
thermoregulation (Brown and Krishnamurthy, 2019). 
In the following paragraph, the importance of an intact skin barrier with functional 
skin immunity is exemplified by the prevalence of inflammatory skin disorders such 
as atopic dermatitis and psoriasis, both of which are chronic skin diseases 
characterized by keratinocytes that respond to opposing aberrant T cell signaling. 
Subsequently, the general components and mechanisms of skin immunity under 
steady-state, during staphylococcal skin colonization and in the context of 
inflammatory skin diseases are illustrated. 
5.1.1 Inflammatory skin disorders: atopic dermatitis and psoriasis 
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder that 
affects 5-20% of infants with higher prevalence in industrialized countries most likely 
due to increased hygienic conditions and concomitant lack of microbial education of 
the immune system (Deckers et al., 2012; Ring et al., 2001; Williams et al., 2008). AD 
is a complex heterogeneous disease with many different factors potentially 
contributing to its development and pathogenesis such as genetic predisposition, 
environmental impacts, skin barrier impairment, T helper type 2 (TH2) cell activation 
and dysbiosis of the skin microbiome. Genome-wide scans have revealed that there 
are many shared chromosome loci among AD patients clearly demonstrating how 
complex this disease is (Bieber, 2008; Eyerich et al., 2015; Weidinger et al., 2018). 
For example, 10% of AD patients are known to have a mutation in the filaggrin (FLG) 
gene, a major component of the stratum corneum. Consequently, this mutation 
results in increased trans-epidermal water loss and skin barrier impairment (Irvine et 
al., 2011). In response to a defective skin barrier, keratinocyte-mediated secretion of 
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cytokines such as thymic stromal lymphopoietin (TSLP), Interleukin (IL)-25 and IL-33 
have emerged as potent key drivers of TH2 inflammation which is considered a 
hallmark of AD (Han et al., 2017). In addition, prolonged antigen penetration through 
the defective barrier may stimulate the observed TH2 infiltrate. It has been reported 
that TH2 and TH22 cytokines such as IL-4, IL-13 and IL-22 are increased in the 
lesional skin of AD patients (Gittler et al., 2012) which in turn lead to the 
downregulation of skin barrier proteins such as filaggrin, loricrin and involucrin by 
keratinocytes (Cornelissen et al., 2012; Howell et al., 2009) thus starting a vicious 
cycle. In line with this, the monoclonal antibody dupilumab, which inhibits Th2 
signaling by blocking the IL-4 receptor has been shown to ameliorate AD (Beck et al., 
2014).  
In addition to TH2 cytokines, a TH2/TH1 switch has been shown to contribute to the 
chronic development of AD while TH22 and TH17 cytokines were shown to contribute 
to the initiation of AD (Czarnowicki et al., 2015; Gittler et al., 2012). Moreover, there 
is increasing evidence that dysbiosis of the microbiome contributes to AD 
development. Opposed to healthy skin, S. aureus is highly prevalent on AD skin and 
therefore drives skin inflammation even further. The reasons for increased S. aureus 
colonization have remained elusive, however, it is likely that altered nutrient 
availability due to barrier impairment as well as the resulting dysbiosis of the 
microbiome contribute to increased S. aureus colonization on AD skin (Kong et al., 
2012). The role of S. aureus in AD is further described in section 5.2.3.2. 
Psoriasis is a chronic inflammatory skin disease characterized by infiltration of 
TH17 cells and neutrophils as well as by hyperproliferation of keratinocytes. During 
psoriasis pathogenesis early danger signals or skin trauma induce infiltration of TH17 
cells into the skin where they secrete TH17 cytokines such as IL-17A/F, IL-21, and IL-
22. Keratinocytes do not express IL-17A/F cytokines but their receptor components 
IL-17RA and IL-17RC (Liang et al., 2006). Binding of IL-17A/F to the IL-17 receptor 
results in the expression of AMPs and neutrophil-attracting chemokines such as 
CXCL8 leading to neutrophil recruitment to the epidermis and initiation of a pro-
inflammatory loop (Albanesi et al., 2007). In addition, IL-17 cytokines induce aberrant 
differentiation of keratinocytes resulting in hyperproliferation and thickening of the 
epidermis (Albanesi et al., 2007). In a psoriasis mouse model, it was recently shown 
that IL-17 signaling in keratinocytes critically contributes to the development of 
psoriasis and that depletion of the IL-17 receptor in keratinocytes but not in T cells, 
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neutrophils or macrophages, protects mice from psoriasis development (Moos et al., 
2019). Moreover, neutralizing therapies against IL-17A are highly efficient in the 
treatment of psoriasis patients (Kurschus and Moos, 2017). Opposed to AD, 
increased levels of IL-17 cytokines and concomitant high levels of AMPs prevent 
increased colonization with S. aureus, however, a role for microbiome dysbiosis has 
also been implicated in the pathogenesis of psoriasis (Visser et al., 2019). 
5.1.2 Antimicrobial peptides of the skin 
AMPs are an evolutionarily conserved component of the innate immune system. 
They are multi-functional host defense peptides with broad spectrum antimicrobial 
activity against a wide range of pathogens including bacteria, fungi, and viruses. 
Additionally, AMPs display other features such as wound healing capacities and 
immuno-modulatory activities and thus provide a link from innate to adaptive 
immunity (Bitschar et al., 2017; Niyonsaba et al., 2017; Niyonsaba et al., 2009a; 
Schittek, 2011). While some AMPs are constitutively expressed, expression of others 
can be induced upon injury or infection (Schittek, 2011). The main cellular sources of 
AMPs in the skin are the keratinocytes but also other skin cells or immune cells 
express AMPs (Niyonsaba et al., 2009a). The major AMP families comprise 
defensins, cathelicidins, dermcidin, S100 proteins and ribonucleases and until today 
above 3000 AMPs have been reported in the AMP database 
(http://aps.unmc.edu/AP/main.php; accessed April 2019): 
Defensins are short cationic peptides which exhibit their antimicrobial activity by 
forming pores in the negatively charged microbial membranes resulting in cell death 
(Niyonsaba et al., 2009a). In contrast to α-defensins, which are mainly expressed by 
neutrophils, β-defensins (hBDs) are predominantly expressed in epithelial cells 
(Niyonsaba et al., 2009a). Generally, hBD1 is considered being constitutively 
expressed in keratinocytes, whereas expression of hBD2, hBD3 and hBD4 can be 
induced in response to bacterial skin infection and pro-inflammatory stimuli. It was 
shown that hBD3 expression in human keratinocytes effectively leads to S. aureus 
killing within minutes of contact with the cell surface (Kisich et al., 2008). However, in 
patients suffering from AD, TH2 cytokines were shown to inhibit the expression of 
hBD3 and also block its antimicrobial activity on S. aureus (Kisich et al., 2008). 
Nevertheless, a stronger induction of hBD3 expression is associated with a more 
favourable clinical outcome of S. aureus skin infections (Zanger et al., 2010). 
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Additionally, it was shown that high baseline expression levels of RNase7 provide 
protection against S. aureus skin infection, while there was no association with hBD2 
or hBD3 expression, suggesting that hBD3 is involved in containment of S. aureus 
infection while RNAse7 expression contributes to infectious susceptibility (Simanski 
et al., 2010; Zanger et al., 2010). 
The only human cathelicidin LL-37, with its precursor human cathelicidin 
antimicrobial protein 18 (hCAP18), is mainly expressed in neutrophils but expression 
can also be induced in keratinocytes upon stimulation with pathogenic bacteria or 
pro-inflammatory stimuli (Niyonsaba et al., 2009a; Schroder and Harder, 2006). By 
inducing pore formation and concomitant membrane disruption, the cationic peptide 
LL-37 exhibits bactericidal and anti-biofilm properties against S. aureus (Dean et al., 
2011; Overhage et al., 2008; Zaiou et al., 2003). Additionally, LL-37 was shown to 
promote wound healing (Carretero et al., 2008) and contributes to homeostasis of the 
epidermal skin barrier (Akiyama et al., 2014). However, in psoriatic skin excessive 
production of AMPs, especially LL-37, was shown to contribute to disease 
pathogenesis (Furue and Kadono, 2019). 
Dermcidin and its proteolytically processed active peptides DCD-1 and DCD-1L, 
on the other hand, are constitutively expressed in eccrine sweat glands where they 
can be transported to the skin surface and serve as an antimicrobial shield (Rieg et 
al., 2004; Schittek et al., 2001). Dermcidin peptides exert a different mode of action 
than most other AMPs: owing to its anionic surface charge dermcidin can interact 
with positively charged Zink ions leading to pore-formation in the bacterial membrane 
and concomitant killing (Becucci et al., 2014; Paulmann et al., 2012). Interestingly, 
AD patients were shown to exhibit a reduced level of dermcidin-derived peptides in 
their sweat which correlated with an impaired ability of their sweat to eradicate viable 
bacteria compared to sweat from healthy people (Rieg et al., 2005; Schittek, 2011). 
When compared to psoriatic skin expression of AMPs was shown to be generally 
reduced in AD (Nomura et al., 2003; Ong et al., 2002), this reduction does not explain 
the increased S. aureus colonization in AD patients because AMP expression was 
still higher than in healthy skin (Harder et al., 2010). 
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5.1.3 Immune cells of the skin 
Many different subsets of innate and adaptive immune cells either reside in or can 
be recruited to the skin. These cell populations, however, are highly dynamic and can 
undergo dramatic changes upon skin infection (Pasparakis et al., 2014). In the 
following paragraphs and in Figure 1 the major innate and adaptive immune cell 
subsets of the skin are described: 
 
Figure 1: Skin structure and immune cells of the skin. Adapted from (Nestle et al., 2009) 
The skin is composed of two layers: the epidermis and the dermis. The epidermis is composed of 
layers of differentiated keratinocytes. The basal layer is the stratum basale which mainly consists 
of undifferentiated keratinocytes, that are constantly renewing the epidermis. During 
differentiation, keratinocytes move towards the outer layers, forming the stratum spinosum, 
stratum granulosum and finally the stratum corneum which consists of terminally differentiated, 
dead and cornified keratinocytes. In addition to keratinocytes, melanocytes and Langerhans cells 
as well as CD8+ T cells are dispersed throughout the epidermis. In addition to fibroblasts and 
blood and lymphatic vessels, the dermis harbors a multitude of different immune cells that 
contribute to tissue homeostasis and skin immunity. While some immune cells can be tissue-
resident (such as macrophages or dermal dendritic cells) others are patrolling or can be recruited 
upon tissue damage or infection (such as monocytes or neutrophils). 
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5.1.3.1 Keratinocytes 
In addition to providing a physical barrier to the environment, keratinocytes as the 
main constituents of the epidermis are responsible for initiation of the magnitude as 
well as the type of local immune responses. During their maturation process 
keratinocytes move from the basal to the uppermost layer of the epidermis where 
they are strategically positioned between the body and the environment to sense 
microbes and thus can subsequently orchestrate adequate immune responses 
(Fuchs and Raghavan, 2002; Segre, 2006). However, keratinocytes are often 
underestimated as part of the innate immune system. Communication of 
environmental signals can be translated by keratinocytes to the immune system by 
expression of different PRRs (see section 5.1.4), activation of which result in distinct 
intrinsic signaling pathways such as mitogen-activated protein (MAP) kinase or 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling 
which in turn lead to the production of different pro-inflammatory cytokines and 
chemokines (SanMiguel and Grice, 2015). Additionally, expression of different 
cytokine and chemokine receptors allows keratinocytes to respond to immunologic 
signals (section 5.1.5). For example, expression of the IL-17A receptor results in 
AMP production by keratinocytes in response to T cells (Liang et al., 2006). The role 
of keratinocytes as sensors and central players in the immune defense against S. 
aureus is further described in Accepted Publication III (Bitschar et al., 2017). 
5.1.3.2  Myeloid cells 
Neutrophils are the most abundant leukocytes of the human blood and the first 
line of defense once pathogens have breached the epithelial barrier. They are usually 
not present in healthy skin but chemokines and cytokines secreted by keratinocytes 
can recruit them along chemotactic gradients to the site of infection in order to clear 
pathogens (de Oliveira et al., 2016; Kolaczkowska and Kubes, 2013). Pathogen 
killing by neutrophils mainly occurs via phagocytosis and subsequent fusion of 
different types of neutrophilic granules with the phagosome. Primary, azurophil 
granules are a specialized form of the lysosome and contain many proteins that are 
directly involved in microbial killing and digestion such as AMPs, myeloperoxidase 
(MPO) or proteinases such as cathepsin G, elastase or proteinase 3 (Segal, 2005). 
Secondary granules mainly contain lactoferrin to bind and sequester iron and copper 
in order to prevent the formation of highly reactive hydroxyl radicals (Britigan et al., 
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1989). Gelatinase, which allows the neutrophil to penetrate endothelial basement 
membranes, is present both in the secondary granules as well as in the tertiary 
granules which, however, do not contain lactoferrin (Segal, 2005). Upon 
phagocytosis, neutrophils intracellularly expose the pathogen to AMPs and reactive 
oxygen species (ROS) followed by an apoptotic differentiation program that limits 
host damage caused by a prolonged inflammatory response (Kennedy and DeLeo, 
2009; Kobayashi et al., 2017). Subsequent clearance of apoptotic neutrophils by 
macrophages, a process referred to as efferocytosis, further prevents excessive 
inflammation and tissue damage (Martin et al., 2012). S. aureus, however, was 
shown to counteract this process by the production of the pore-forming a-toxin which 
lyses neutrophils and by this promotes necroptosis and a concomitant inflammatory 
response (Cohen et al., 2016; Greenlee-Wacker, 2016; Greenlee-Wacker et al., 
2014). Apart from inhibition of macrophage efferocytosis, S. aureus has evolved 
multiple other strategies to evade neutrophil-mediated phagocytosis (Guerra et al., 
2017). These strategies are further described in section 5.2.3 as well as in Accepted 
Publication III.  
The discovery of neutrophil extracellular traps (NETs) significantly contributed to 
the repertoire of weapons employed by neutrophils to kill bacteria (Brinkmann et al., 
2004): NETs are large extracellular, web-like structures composed of granule 
proteins and AMPs that are assembled on decondensed chromatin and are extruded 
from neutrophils in order to trap and kill microbes (Brinkmann et al., 2004). The 
composition of NET proteins as well as the pathways that lead to NET formation were 
shown to vary depending on the stimulus (Boeltz et al., 2019; Kenny et al., 2017). 
Figure 2 schematically illustrates the formation of NETs by neutrophils. Generally, 
neutrophils first arrest their actin dynamics and depolarize (Metzler et al., 2014), 
followed by disassembly of the nuclear envelope and decondensation of nuclear 
chromatin into the cytoplasm where it mixes with cytoplasmic and granule 
components (Fuchs et al., 2007). Here, neutrophil elastase and MPO binding of 
chromatin was shown to synergistically drive chromatin unpacking (Papayannopoulos 
et al., 2010). Moreover, global activation of transcription at multiple loci as well as 
hypercitrullination (Wang et al., 2009) and proteolytic degradation (Urban et al., 2009) 
of histones was shown to further promote chromatin decondensation (Khan and 
Palaniyar, 2017). Finally, the plasma membrane permeabilizes, and NETs expand 
into the extracellular space 3-8 hours after neutrophil activation (Papayannopoulos, 
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2018). Additionally, alternative mechanisms that describe non-suicidal pathways of 
NET formation are described in the literature: For example, exposure to S. aureus 
was shown to lead to rapid, non-lytic secretion of chromatin and granules (Pilsczek et 
al., 2010). Yipp et al. (2012) further describe the occurrence of anuclear “neutrophil 
ghosts”, referring to a state after NET formation where cellular functions such as 
chemotaxis and phagocytosis remain intact (Yipp et al., 2012). 
 
 
Figure 2: Schematic representation of neutrophil extracellular trap formation 
Neutrophils typically possess a multi-lobed nucleus (blue) and several granules (dark blue). In 
order to form NETs, neutrophils first arrest their actin dynamics followed by disassembly of the 
nuclear envelope (dashed line) and decondensation of nuclear chromatin (orange). In the 
cytoplasm nuclear chromatin mixes with cytoplasmic and granule components such as neutrophil 
elastase and myeloperoxidase which further drives chromatin unpacking. Finally, the plasma 
membrane permeabilizes and NETs expand into the extracellular space. 
Dendritic cells (DCs) in humans and mice are classified as plasmacytoid and 
conventional DCs. In peripheral tissues, conventional DCs can be further categorized 
into tissue-resident and migratory DCs (Merad et al., 2013). Specialized skin-resident 
DCs are the Langerhans cells (LCs) which are representatives of the migratory DCs 
and colonize the epidermis as well as other epithelia such as the gastrointestinal or 
bronchial tracts (Sparber, 2014). LCs arise from hematopoietic precursors and seed 
the epidermis before birth. During the first week after birth LCs proliferate and create 
a dense network in the epidermis where they constitute approximately 3% of all cells 
(Chorro et al., 2009). Thereby, a paracrine supply of TGF-β provided by 
keratinocytes is needed for the development and survival of LCs (Kaplan et al., 
2007). Their dendritic morphology extends through tight junctions to the stratum 
corneum where LCs capture microbial antigens (Nagao et al., 2009). LCs express a 
wide variety of PRRs including surface C-type lectins such as langerin (CD207) 
(Valladeau et al., 2000) or CD1a (Salamero et al., 2001). These PRRs recognize 
mannosylated ligands found on the surface of a wide range of microbes (Dambuza 
and Brown, 2015; Figdor et al., 2002) and induce antigen internalization and 
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trafficking to the Birbeck granules where antigens are processed (Stossel et al., 
1990; Valladeau et al., 2000). Upon antigen recognition and processing LCs 
upregulate MHC class II and concurrently migrate to regional lymph nodes where 
antigens are presented to naïve T cells (Koch et al., 2006). Thereby, the presence of 
distinct LC-secreted cytokines determines the type of induced immune response. It 
appears that LCs are capable of inducing both tolerance as well as immunity 
(Atmatzidis et al., 2017): For example, in mice LCs were shown to promote the 
induction of Th17 cells in response to extracellular pathogens, while it has also been 
observed that LC-mediated antigen-presentation results in the depletion of T cells 
suggesting an immuno-regulatory role (Igyarto et al., 2011; Igyarto and Kaplan, 
2013). Compensation for emigrated LCs is carried out both by adjacent proliferative 
LCs (Ghigo et al., 2013) as well as replacement of epidermal LCs by monocytes 
(Nagao et al., 2012; Sere et al., 2012). LC maintenance and repopulation were 
shown to depend on keratinocytes signaling via colony stimulating factor 1 receptor 
(CSF1R), Macrophage colony stimulating factor (M-CSF), IL-1, tumor necrosis factor 
α (TNFα), CC-chemokine ligand 2 (CCL2) and CCL20 (Kimber et al., 2000; Nagao et 
al., 2012).  
In addition to LCs, multiple different subsets of dermal DCs were identified in 
human and murine skin and were shown to contribute to cutaneous immunity both 
during skin homeostasis and skin infection (Tomura et al., 2014). For example, in 
murine skin S. epidermidis-induced accumulation of CD8+ T cells was shown to be 
dependent on a subset of CD103+ dendritic cells (Naik et al., 2015). 
In addition to keratinocytes and LCs, resident skin macrophages are early 
detectors of pathogens entering the body through the skin and can initiate an 
inflammatory host response (Pasparakis et al., 2014). They are specialized in 
phagocytosis and neutralization of cellular debris and potentially host cell damaging 
agents including pathogens. In contrast to LCs, which trigger remote T cell responses 
upon translocation to tissue-draining lymph nodes, tissue-resident macrophages are 
non-migratory cells that locally monitor their immediate and adjacent surroundings 
(Mildner and Jung, 2014; Varol et al., 2015). Similarly to LCs, the majority of tissue-
resident macrophages is established prenatally but macrophages can also develop in 
adulthood from tissue-infiltrating monocytes (Varol et al., 2015). Based on their 
function macrophages can generally be divided into three groups: The classically-
activated pro-inflammatory M1 macrophages, regulatory M2 macrophages and 
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wound-healing macrophages. There is accumulating evidence that macrophages 
contribute to both acute and chronic inflammation in the skin: For example, pro-
inflammatory M1 macrophages were abundantly observed in psoriatic skin (Fuentes-
Duculan et al., 2010; Wang et al., 2019) as well as in skin lesions of AD patients 
(Kiekens et al., 2001). By contrast, regulatory M2 macrophages secrete IL-10 and 
TGFb and thus have an essential role in resolution and dampening of skin 
inflammation (Mantovani et al., 2013). In S. aureus skin infection, upregulation of 
phagocytosis in M2 macrophages significantly contributed to infection clearance and 
prevention of excessive inflammation by limiting the number of available pathogens 
(Chiang et al., 2012). 
Mast cells are hematopoietic cells that circulate in the blood in an immature state. 
Depending on the stimulus mast cells migrate to peripheral tissues and mature into 
multi-faceted effector cells which can exert a variety of different functions involved in 
immunity. They can activate and recruit other effector cells, directly neutralize 
microbes and are also involved in tissue remodeling and angiogenesis (Dudeck et al., 
2018). In the skin, maturation of mast cells was shown to be dependent on 
microbiome-induced TLR2-mediated secretion of stem cell factor by keratinocytes 
(Wang et al., 2017). Within their cytoplasmic granules, large amounts of pre-formed, 
pro-inflammatory mediators are stored which can be rapidly released upon pathogen 
recognition in order to guarantee fast host protection. TLR2-mediated sensing of S. 
aureus was shown to result in rapid degranulation and discharge of AMPs and TNFα 
resulting in direct killing of S. aureus as well as in recruitment of other effector cells 
(Abel et al., 2011). However, mast cell-mediated release of IgE was also shown to 
contribute to AD pathogenesis. AD patients are frequently colonized with S. aureus 
and IgE antibodies directed against staphylococcal antigens are commonly found in 
their blood (Bunikowski et al., 1999; Ide et al., 2004; Leung et al., 1993). In an 
epicutaneous mouse skin colonization model staphylococcal δ-toxin was identified to 
be responsible for enhanced IgE and IL-4 production and concomitant inflammation 
enhancement. Additionally, it was shown that S. aureus strains isolated from AD 
patients produce large amounts of δ-toxin (Nakamura et al., 2013). Moreover, 
lesional skin of AD patients harbor high amounts of mast cells (Liu et al., 2011) and 
since S. aureus was also shown to survive and hide within mast cells, these cells 
might also serve as a reservoir of viable bacteria in AD skin (Nakamura et al., 2013). 
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5.1.3.3 Lymphoid cells 
The innate lymphoid cell (ILC) family comprises lymphoid tissue-inducer cells, 
cytotoxic natural killer (NK) cells and non-cytotoxic ILCs. Similar to CD8+ cytotoxic T 
cells, cytotoxic NK cells are involved in killing infected and tumor cells, while non-
cytotoxic ILCs are the innate counterparts to effector T cells. ILCs can be further sub-
grouped into ILC1,2 and 3. Analog to their effector T cell subsets, the ILC subgroups 
are defined based on their required transcription factors during development and 
their cytokine expression patterns. While ILC1s are implicated in immunity against 
intracellular pathogens, ILC2s produce TH2 cytokines and thus promote type 2 
inflammation in response to parasites and allergens. Consequently, ILC3s produce 
TH17 cytokines and promote antibacterial and antifungal immunity. However, unlike 
their effector T cell counterparts, ILCs lack expression of somatically rearranged 
antigen receptors and thus act in an antigen-independent manner (Artis and Spits, 
2015; Vivier et al., 2018; Yang et al., 2017). While NK cells circulate in the blood, 
ILCs are tissue-resident cells that are preferentially enriched in barrier tissues such 
as the skin, where they can instantly react to cytokines and other signals expressed 
by surrounding cells and participate in local host defense, tissue homeostasis and 
inflammation (Artis and Spits, 2015; Vivier et al., 2018; Yang et al., 2017). In lesional 
skin of AD patients elevated levels of TH2 cytokine-producing ILC2s have been 
reported (Kim et al., 2013; Salimi et al., 2013). Moreover, in a mouse model of AD 
ILC2s were critically involved in the development of AD-like skin inflammation. 
Strikingly, ILC2-mediated AD-like inflammation was dependent on TSLP expression 
in mouse skin (Kim et al., 2013). In conclusion, due to their TH2 analogy ILC2s might 
also contribute to the pathology of AD. 
In addition to innate immune cells, representatives of adaptive immunity are 
largely present in the skin. It is estimated that 2*1010 T cells reside in healthy human 
skin which equals twice the number of T cells in the blood (Clark et al., 2006). 
Following microbial encounters, LCs migrate from the skin to the draining lymph 
nodes where microbial antigens are presented to naïve T cells (Koch et al., 2006). 
This results in the generation of effector and memory T cells that travel to the site of 
infection (Edele et al., 2008; Mora et al., 2005). Thereby the cytokine profile of the LC 
determines whether T cells undergo TH1, TH2 or TH17 polarization (Atmatzidis et al., 
2017). Effector T cells eradicate the infection and following infection resolution the 
majority of effector T cells dies while a small number becomes memory T cells which 
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either recirculate or reside in the skin where they are strategically positioned to 
provide a first response upon re-encounter with skin pathogens (Mueller et al., 2013). 
In contrast to human skin, which is mainly populated by CD4+ or CD8+ Tαβ cells, 
murine skin is densely populated with Tγδ cells which seed the skin before birth (Jiang 
et al., 2010). Unlike αβT cells, Tγδ cells do not recognize peptides bound to MHC 
molecules and until today the antigens recognized by Tγδ cells remain largely 
unknown but are believed to play a role in microbial recognition (Adams et al., 2015). 
Indeed, it was shown that commensals drive the expansion of Tγδ cells at barrier sites 
in an IL-1 and IL-23-dependent manner (Duan et al., 2010; Naik et al., 2012). In 
addition, Tγδ cells can also be directly activated by cytokines such as IL-1 cytokines 
and IL-23 (Gray et al., 2011). 
The magnitude of an immune response is effectively controlled by regulatory T 
cells (Tregs) which comprise 5–10% of all skin-resident T cells (Clark et al., 2006). In 
addition to that, most blood-circulating Tregs express skin-homing markers suggesting 
constitutive trafficking and patrolling to the skin (Hirahara et al., 2006). Tregs are key 
regulators of immune tolerance and block excessive inflammatory responses by the 
production of inhibitory cytokines, cytolysis of effector cells, metabolic disruption or 
modulation of DC function (Sakaguchi, 2005). In addition, Tregs were shown to 
facilitate cutaneous wound healing (Nosbaum et al., 2016). Interestingly, a large 
proportion of Tregs can be found in close proximity to the hair follicles which serve as 
a natural habitat for the microbiota (Sanchez-Rodriguez et al. 2014). Here, Tregs 
regulate the proliferation and differentiation of hair follicle stem cells (Ali et al., 2017). 
Moreover, during hair follicle development and concomitant commensal colonization, 
murine skin is populated by a wave of Tregs that provides tolerance to commensals 
also in the context of skin inflammation (Scharschmidt et al., 2017; Scharschmidt et 
al., 2015). 
Although T cells coordinate cutaneous immune responses against 
microorganisms and cancer, aberrant and inappropriate T cell activation can lead to 
chronic inflammatory disorders such as AD or psoriasis. Interestingly, AD and 
psoriasis where shown to have opposing T cell cytokine profiles: While AD is 
dominated by infiltrates with TH2 cells, psoriasis is driven by TH17 cells (Eyerich et 
al., 2011).  
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5.1.4 Pattern recognition receptors 
Keratinocytes and other cells of the innate immune system express several PRRs 
which are located on the cell surface, in endosomes or in the cytoplasm and detect 
pathogen-associated molecular patterns (PAMPs) or endogenous danger-associated 
molecular patterns (DAMPs) (Akira et al., 2001; Janeway and Medzhitov, 2002). 
Activation of PRRs in keratinocytes results in the production of AMPs and pro-
inflammatory cytokines and chemokines by which subsequent adequate immune 
responses are induced. The innate immune system comprises several classes of 
PRRs which allow the early detection of potential pathogens: Toll-like receptors 
(TLRs), C-type-lectin receptors (CLRs), NOD-like receptors (NLRs) and RIG-I-like 
receptors (RLRs) (Perez-Lopez et al., 2016). The membrane bound TLRs and CLRs 
detect PAMPs in the extracellular milieu and in the endosomal compartment. TLRs 
and CLRs can also cooperate with other PRRs such as RNA-sensing RIG-I-like 
receptors or DNA-sensing NLRs. For example, in the presence of TLR signals S. 
aureus-induced NOD2 activation amplified an inflammatory response in DCs (Volz et 
al., 2010). Upon cellular stress such as infection or metabolic deregulation NLRs can 
form high molecular weight complexes called inflammasomes which play a central 
role in the control of pro-inflammatory immune responses mainly by secretion of IL-
1β (Franchi et al., 2009; Ishii et al., 2006). 
5.1.4.1 Toll-like receptors 
TLRs are a family of evolutionary conserved PRRs expressed by a variety of cell 
types involved in innate immunity (Akira et al., 2001; Janeway and Medzhitov, 2002). 
They are type I membrane glycoproteins characterized by a cytoplasmic TIR 
(Toll/Interleukin-1 receptors (IL-1R)) domain and a leucine-rich repeat ectodomain 
used for pathogen recognition. They are capable of detecting both exogenous 
PAMPs such as bacterial lipopeptides, lipopolysaccharide (LPS), flagellin, bacterial or 
viral DNA and endogenous DAMPs released by dying or damaged cells such as 
High-Mobility-Group-Box 1 (HMGB1), heat shock proteins and β-defensins (Akira et 
al., 2006). Activation of TLR signaling pathways results in the recruitment of the 
intracellular adaptor proteins myeloid differentiation primary response protein 88 
(MyD88) or toll-like receptor adaptor molecule 1 (TRIF): MyD88 is universally used by 
all TLRs, except for TLR3, and activates the transcription factor NF-kB and MAP 
kinase signaling to induce the expression and release of various pro-inflammatory 
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cytokines and chemokines. By contrast, TRIF is used by TLR3 and TLR4, which 
uniquely uses both adaptor molecules, and induces the activation of the transcription 
factors IRF3 and NF-kB and consequently induces type I interferons as well as pro-
inflammatory cytokines (Akira et al., 2006; Gay et al., 2014). 
Keratinocytes express the cell surface-associated TLRs 1, 2, 4, 5 and 6 and the 
endosomal TLRs 3 and 9 (Miller and Modlin, 2007) (Figure 3). In addition, TLR7 
expression can be induced by TLR3-mediated recognition of dsRNA in keratinocytes 
(Kalali et al., 2008). TLR2 is the predominant receptor recognizing staphylococcal 
lipoproteins and lipopeptides (Nguyen and Gotz, 2016; Takeuchi et al., 2000). 
Binding of S. aureus lipoproteins to TLR2 results in heterodimerization of TLR2 with 
TLR1 or TLR6 which then translates via MyD88 and NF-kB activation into induction 
of pro-inflammatory cytokine and AMP expression (Kawasaki and Kawai, 2014). 
Thereby, the degree of acylation of bacterial lipoproteins influences the consecutive 
immune response (Nguyen and Gotz, 2016). Upon recognition of tri-acylated 
lipoproteins, TLR2 forms heterodimers with TLR1, whereas TLR2-TLR6 heterodimers 
recognize di-acylated lipoproteins (Jin et al., 2007; Kang et al., 2009). While Gram-
positive bacteria were thought to mainly contain tri-acylated lipoproteins, both di-and 
tri-acylated lipoproteins were described in S. aureus (Asanuma et al., 2011; 
Tawaratsumida et al., 2009). Interestingly, di-acylated lipoproteins are mainly found 
in S. aureus during stationary phase or in acidic pH suggesting that acylation is 
largely dependent on environmental conditions (Kurokawa et al., 2012). 
Moreover, TLR2 can cooperate with other co-receptors on the cell surface which 
expands the spectrum of TLR2 ligands. For example, the scavenger receptor CD36 
seems to play a role in S. aureus recognition by TLR2: CD36-deficient mice display 
increased susceptibility to S. aureus as well as other TLR2 ligands (Hoebe et al., 
2005). Moreover, the lipopeptide LP01 produced by S. epidermidis induced 
enhanced antimicrobial defense against S. aureus in keratinocytes via the 
TLR2/CD36 signaling axis (Li et al., 2013). 
Interestingly, unsaturated fatty acids from skin can be incorporated into bacterial 
lipoproteins, which results in amplification of TLR2-dependent immune stimulation 
(Nguyen et al., 2016). In addition, it has recently been shown that phenol-soluble 
modulins (PSMs) produced by staphylococci can release lipoproteins from the 
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bacterial cell envelope leading to increased TLR2 stimulation of host cells 
(Hanzelmann et al., 2016). 
Ligand binding to TLRs must be tightly regulated to ensure appropriate immune 
and inflammatory responses. Therefore, host and bacteria have evolved several 
mechanisms that negatively regulate TLR signaling (Askarian et al., 2014; Kawai and 
Akira, 2010; Rahman and McFadden, 2011). On the host side, expression levels of 
TLR2 and its co-receptors regulate the sensitivity to several TLR2 ligands. 
Additionally, soluble decoy TLRs, splice variants for adaptor proteins and miRNAs 
can inhibit TLR and NF-kB signaling (Kawai and Akira, 2010). On the pathogen side, 
S. aureus, as well as other pathogens, were shown to express TIR-domain-
containing proteins, which were shown to inhibit TLR2-mediated NF-kB signaling 
(Askarian et al., 2014; Wagner et al., 2018; Zou et al., 2014). Further mechanisms of 
S. aureus to counteract TLR-mediated immune activation are described in section 
5.2.3. 
Since TLRs are essential for protective immunity against infection, inappropriate 
or malfunctioning TLR responses can contribute to acute and chronic inflammation. 
During homeostasis self-derived nucleic acids do not activate TLRs due to 
endolysosomal localization of TLR7 and TLR9 and due to effective degradation of 
nucleic acids by serum nucleases (Barton et al., 2006). However, LL-37, which is 
highly abundant in psoriatic skin, was shown to form stabilizing aggregates with DNA 
and RNA which can subsequently be endocytosed by DCs and activate TLR7 and 
TLR9 leading to promotion of skin inflammation (Ganguly et al., 2009; Lande et al., 
2007). Additionally, responsiveness of TLR2 to S. aureus seems to be lower in AD 
skin due to a TLR2 polymorphism (Arg753GLN) which renders the intracellular 
signaling domain inactive. This mutation correlated with increased S. aureus skin 
infections and was associated with a more severe phenotype of AD (Bin and Leung, 
2016; Brown, 2017). Moreover, many AD patients express lower amounts of TLR2 in 
skin cells and produce less pro-inflammatory cytokines after TLR2 stimulation 
compared to healthy humans (Skabytska et al., 2016). In addition to TLR2, also 
TLR9, NOD1 and NOD2 polymorphisms were described to correlate with an 
increased risk for AD (Bin and Leung, 2016; Brown, 2017) indicating that sensing of 
microbial products which are potentially involved in AD pathology involves not just 
one TLR ligand but a whole array of ligands that signal via different PRRs. 
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Figure 3: Simplified schematic overview of Toll-like receptors and their signaling networks 
in human keratinocytes 
Depicted are the TLR receptors expressed in human keratinocytes as well as their key adaptors 
and downstream mediators that are essential for effective host response to infection. Once 
activated by the indicated ligands, TLRs recruit their specific adapters MyD88 or TRIF. All TLRs 
universally use MyD88 as an adapter protein, except for TLR3 which uses TRIF. Recruitment of 
MyD88 results in further recruitment of IRAK4, IRAK2, IRAK1 and TRAF6. Association of IRAK1 
and TRAF6 with TAK1 leads to TAK1 activation followed by activation of NF-kB and MAP kinase 
signaling to induce gene expression of pro-inflammatory cytokines. Endosomal activation of 
MyD88-dependent TLR signaling, however, results in the activation of IRF7 via TRAF3, leading to 
transcription of typeI interferons. TRIF-dependent signaling also results in the activation of TRAF3 
and concomitant IRF3 activation and transcription of typeI interferons. IRAK = Interleukin-1 
receptor-associated kinase; IRF = Interferon regulatory factor; DNA = deoxyribonucleic acid; LPP 
= Lipoprotein; LPS = Lipopolysaccharide; MyD88 = Myeloid differentiation primary response gene 
88; NF-κB = nuclear factor kappa light chain enhancer of activated B cells; dsRNA/ssRNA = 
double-stranded/ single-stranded ribonucleic acid; TAK1 = Transforming growth factor β activated 
kinase 1; TLR = Toll-like receptor; TRAF = Tumor necrosis factor receptor associated factor; 
TRIF = TIR domain containing adapter-inducing interferon-β. 
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5.1.5 Cytokines and chemokines 
Keratinocytes as the initial sensors of environmental stimuli as well as other skin-
resident cells are equipped with a variety of cytokines and chemokines which upon 
release contribute to skin barrier homeostasis and determine subsequent immune 
reactions. While some cytokines are constitutively expressed in the skin, expression 
of others can be induced upon injury or infection. TLR stimulation in response to S. 
aureus, for example, results in NF-kB activation and production of pro-inflammatory 
cytokines and chemokines such as IL-1, IL-6, TNFa or CXCL8 resulting in neutrophil 
recruitment and AMP production (Figure 4a) (Krishna and Miller, 2012). Deregulated 
cytokine expression, however, can contribute to epidermal barrier dysfunction as it is 
observed in AD. In the following the major cytokines and chemokines of the skin are 
described in more detail. Additionally, the role of cytokines and chemokines during S. 
aureus skin infection as well as during inflammatory skin diseases is depicted in 
Figure 4. 
5.1.5.1 Cytokines 
IL-1 family cytokines play a major role in skin homeostasis and immunity. IL-1α 
is constitutively expressed in keratinocytes and stored in the epidermis (Hauser et al., 
1986; Kupper, 1990). Thus the epidermis is shielded by IL-1α which can either be 
passively released in response to injury or actively in response to infection (Figure 
4a) (Murphy et al., 2000). Interestingly, in a 3D organotypic skin model IL-1a 
expression in keratinocytes was shown to be dependent on stimulation of the aryl 
hydrocarbon receptor with the commensal S. epidermidis (Rademacher et al., 2019). 
IL-1α is active in its pro-form, however, proteolytic processing dramatically increases 
its biological activity (Afonina et al., 2015). Interestingly, cleavage of IL-1α can be 
exerted by pro-inflammatory proteases derived from NK cells or neutrophils such as 
granzyme B or elastase (Figure 4a) (Afonina et al., 2011). Similarly, IL-36 cytokines, 
which also belong to the IL-1 cytokine family, can be released by keratinocytes upon 
tissue injury or microbial stimulation. Cleavage of IL-36 by the neutrophil proteases 
cathepsin G, elastase and proteinase-3 and not by keratinocyte-derived proteases, 
highly increased the pro-inflammatory effects of IL-36 cytokines on keratinocytes 
(Figure 4a) (Henry et al., 2016). Therefore, cleavage of these cytokines bears an 
intrinsic safeguard mechanism where inflammation is only potentiated in the 
presence of inflammatory immune cell infiltrates and potential harmful inflammation 
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can be prevented in their absence. During injury, dysbiosis and skin barrier 
impairment caused by filaggrin deficiency, however, skin inflammation was shown to 
be driven through keratinocyte-mediated IL-1α release (Archer et al., 2019). 
In contrast to IL-1α, IL-1β requires inflammasome-dependent cleavage by 
caspase-1 in order to be biologically active (Kostura et al., 1989; Thornberry et al., 
1992). Thereby, release of active IL-1β requires two signals: The first signal is the 
priming signal that can be triggered by different infectious or non-infectious threats 
that result in NF-kB activation followed by transcription and translation of pro-IL-1β. 
The second signal is the activating signal by which NLR-mediated sensing of PAMPs 
or DAMPs results in oligomerization of the multi protein signaling complex termed the 
inflammasome. Finally, recruitment of caspase-1 forms the active inflammasome 
resulting in caspase-1 cleavage and activation and concomitant IL-1β-driven 
inflammation (Lamkanfi and Dixit, 2014). Upon intradermal S. aureus infection of the 
skin, the inflammasome is activated and IL-1β secretion results in the recruitment of 
neutrophils (Brauweiler et al., 2019; Miller et al., 2007). 
Tumor necrosis factor α (TNFα) is a pleiotropic and highly inflammatory 
cytokine that induces a wide range of other immune cell–attracting cytokines and 
chemokines as well as AMPs. TNFa can be released in high amounts in response to 
bacteria-mediated TLR activation and thus plays a huge role in host defense. Binding 
of TNFα to its receptors activates the two major transcription factors activator protein 
1 and NF-κB, that in turn induce genes involved in inflammatory responses (Waters 
et al., 2013). In response to S. aureus skin infection as well as tape-stripping TNFa is 
upregulated in murine skin (Wanke et al., 2013). Moreover, due to its highly 
inflammatory capacity, different biologics targeting TNFa are commonly used in the 
treatment of chronic inflammatory diseases such as psoriasis (Kurschus and Moos, 
2017; Sabat et al., 2019).  
IL-2 family cytokines include IL-4, IL-13 and IL-21, the prototypic TH2 cytokines 
which have been extensively studied in the pathogenesis of AD (Figure 4b). 
Expression of these cytokines is strongly up-regulated in the skin of AD patients 
(Neis et al., 2006) as well as in mouse skin upon tape-stripping (Jin et al., 2009). 
Treatment of keratinocytes with IL-4 in combination with IL-13 leads to a reduced 
expression of skin barrier proteins such as filaggrin, loricrin and involucrin 
(Cornelissen et al., 2012; Howell et al., 2009). Mice treated with recombinant IL-4 
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show a reduced epidermal thickness (Hatano et al., 2013) whereas mice 
overexpressing IL-4 or IL-13 in keratinocytes, spontaneously develop an 
inflammatory skin reaction that displays many features of AD including S. aureus 
colonization (Chan et al., 2001; Zheng et al., 2009). In line with this, IL-4-ko mice 
develop a strengthened skin barrier and are protected from the development of 
STAT6-induced allergic skin inflammation (Sehra et al., 2010). 
IL-1 cytokines and TNFa cytokines as well as TLR activation are also major 
activators of IL-6 cytokine expression (Hunter and Jones, 2015). Concurrently, IL-6 
deficiency leads to impaired immunity against microbial infection (Kopf et al., 1994; 
Neveu et al., 2009; van der Poll et al., 1997) and children with inhibitory 
autoantibodies against IL-6 develop recurrent staphylococcal infections (Puel et al., 
2008). Similarly, patients with STAT3 mutations, which are common among AD 
patients (Weidinger et al., 2018), show impaired IL-6 activity and are susceptible to 
recurrent staphylococcal skin infections (Freeman and Holland, 2010). Additionally, 
IL-6 is involved in wound healing (Lin et al., 2003) and keratinocyte proliferation (Sato 
et al., 1999). Another member of the IL-6 cytokine family is IL-31 which induces AMP 
expression in an IL-1a-dependent manner during skin homeostasis (Hanel et al., 
2016). Since IL-31 is mainly produced by TH2 cells but its receptor is expressed by a 
wide range of cells including keratinocytes this implies a role for IL-31 in AD 
pathogenesis (Kato et al., 2014). Indeed, AD patients show significant higher levels 
of IL-31 mRNA in serum and lesional skin samples (Kim et al., 2011). Moreover, IL-
31 interferes with keratinocyte differentiation and represses filaggrin expression 
(Cornelissen et al., 2012). Clinical trials have revealed that administration of an anti-
IL-31 receptor antibody significantly alleviates pruritus in patients with AD (Furue et 
al., 2018). 
IL-17 family cytokines comprise six members, IL-17A-F (Gaffen, 2011). IL-17A 
and IL-17F are the signature cytokines for TH17 cells (Yao et al., 1995) but the main 
producers also include CD8+ cytotoxic T cells as well as Tγδ cells and ILC3s 
(Kurschus and Moos, 2017). Keratinocytes, on the other hand, mainly produce IL-
17C in response to pro-inflammatory and bacterial stimuli including S. aureus 
(Ramirez-Carrozzi et al., 2011; Roth et al., 2014). The receptor for IL-17A/F, 
however, is expressed quite ubiquitously including in keratinocytes, whereas IL-
17RE, the receptor for IL-17C, is rather expressed on non-hematopoietic cells such 
Introduction 
 36 
as keratinocytes (Kurschus and Moos, 2017). Thereby, the responses of 
keratinocytes to IL-17C and IL-17A/F are very similar (Ramirez-Carrozzi et al., 2011). 
IL-17 ligand binding to the IL-17 receptor results in NF-kB and ERK activation which 
ultimately leads to the expression of other pro-inflammatory cytokines and 
chemokines such as IL-6, IL-36 and CXCL8 as well as AMP production. Therefore, 
IL-17 cytokines induce a host response and initiate neutrophil infiltration into infected 
tissues. Thereby, IL-17 signaling is important in cutaneous defense against several 
bacteria and fungi (Li et al., 2018) and major roles have been described for S. aureus 
(Cho et al., 2010). Despite its beneficial effects in host defense, IL-17 is also 
implicated in several inflammatory diseases such as psoriasis where the IL-17 
signaling axis is crucial for pathogenesis (Figure 4c) (Furue and Kadono, 2019) and 
targeting monoclonal antibodies are widely approved for therapy (Kurschus and 
Moos, 2017). Since IL-17 was shown to act in synergy with other pro-inflammatory 
cytokines such as TNFα (Ruddy et al., 2004) or IL-1β (Iyoda et al., 2010)  the main 
function of TNFα-targeting antibodies in psoriasis may be the inhibition of synergy 
with IL-17. Additionally, synergistic AMP induction of IL-22 and IL-17 are the main 
cause for impaired keratinocyte cornification observed in psoriasis (Wolk et al., 
2006). Finally, IL-17C neutralization has been shown to ameliorate skin inflammation 
in mouse models both of psoriasis and AD (Vandeghinste et al., 2018).  
Other cytokines important in skin immunity include interferons which are mainly 
involved in anti-viral immune defense, members of the IL-12 cytokine family such as 
IL-23 as well as regulatory cytokines such as IL-10 (Hanel et al., 2016). 
5.1.5.2 Chemokines 
Chemokines are small chemotactic molecules that can be classified into four 
groups based on the position of the conserved cysteine residues: CXC, CC, C and 
CX3C (Zweemer et al., 2014). Chemokines typically interact with G protein-coupled 
chemokine receptors by which diverse signals leading to leukocyte migration, 
inflammation and differentiation are transmitted (Nourshargh and Alon, 2014; Tan et 
al., 2015). 
CXCL1, CXCL2 and CXCL8 primarily recruit neutrophils to the site of 
inflammation by binding to the chemokine receptors CXCR1 and CXCR2 
(Rajarathnam et al., 2019). CXCL8 expression is mainly regulated by NF-κB 
activation in response to TLR2 activation but expression can also be induced by pro-
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inflammatory cytokines such as TNFα and IL-1 cytokines (Krishna and Miller, 2012). 
Rodents lack CXCL8 but the chemokines keratinocyte chemoattractant (KC), 
macrophage inflammatory protein 2 (MIP-2) and LPS-induced CXC-chemokine (LIX) 
are regarded as functional homologues since they represent closely related 
chemokines that effectively recruit neutrophils (Zlotnik and Yoshie, 2000). 
Moreover, keratinocytes are important sources of T cell recruiting chemokines in 
the skin: By expressing CXCL9, CXCL10, and CXCL11 activated keratinocytes 
attract different subtypes of T cells into the skin and thereby orchestrate skin 
inflammation (Nestle et al., 2009). Furthermore, commensal-induced CCL20 
expression in keratinocytes at the hair follicles was shown to drive Treg migration into 
neonatal mouse skin which leads to the establishment of tolerance towards 
commensals (Scharschmidt et al., 2017; Scharschmidt et al., 2015). 
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Figure 4: The role of cytokines and chemokines during S. aureus infection and 
inflammatory skin diseases 
a) The epidermis is shielded by keratinocyte-mediated IL-1α production (green shield) which can 
either be passively released in response to injury or actively in response to infection. Upon S. 
aureus infection of the skin, diverse pro-inflammatory cytokines and chemokines such as IL-1β, 
IL-6, TNFα, CXCL8, CXCL2 and CXCL1 are secreted by keratinocytes in order to recruit 
phagocytic cells to clear the infection. At the same time neutrophil-derived proteases can cleave 
IL-1α and IL-36 into their active forms to potentiate keratinocyte-mediated paracrine pro-
inflammatory signaling. Pro-inflammatory cytokines can in turn induce the expression of AMPs in 
keratinocytes. b) In response to an impaired skin barrier (dashed red line), keratinocyte-mediated 
secretion of cytokines such as TSLP, IL-25 and IL-33 drive TH2 inflammation. TH2 cytokines lead 
to the downregulation of skin barrier proteins such as filaggrin, loricrin and involucrin by 
keratinocytes thus starting a vicious cycle. c) During psoriasis skin-infiltrating TH17 cells secrete 
TH17 cytokines such as IL-17A/F. Keratinocytes do not express IL-17A/F cytokines but their 
receptor components. Binding of IL-17A/F to the IL-17R results in the expression of AMPs and 
chemokines such as CXCL8 leading to neutrophil recruitment to the skin where they secrete LL-
37 and initiate a pro-inflammatory loop. In addition, IL-17 cytokines induce aberrant differentiation 
of keratinocytes resulting in hyperproliferation and thickening of the epidermis. IL = Interleukin; 
CXCL = C-X-C motif ligand; TNFα = Tumor necrosis factor α; TSLP = thymic stromal 
lymphopoietin; AMP = Antimicrobial peptide. 
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5.2 The skin microbiome 
Our body contains an estimated composition of 1012 microbes (Ley et al., 2006) in 
the gut and 1010 in the skin (Grice et al., 2008). However, compared to the gut, our 
skin provides poor nutrient availability to its colonizing microbes. Therefore, the 
resident microbiota has adapted and utilizes the limited resources present in our 
sweat, sebum and stratum corneum. Colonizing staphylococci for example have 
evolved diverse strategies to ensure survival on the skin. In addition to being halo-
tolerant, they can use the urea in the sweat as a nitrogen source. Moreover, 
staphylococci express proteases that liberate nutrients from the stratum corneum. 
Interestingly, colonizing malassezia and corynebacteria are unable to produce their 
own lipids and utilize the lipid compounds present in the sebum and stratum 
corneum. Therefore, compared to other fungi, malassezia genomes are enriched in 
genes encoding for lipid metabolism and genes involved in carbohydrate metabolism 
are depleted. Moreover, by releasing proteases and lipases propionibacteria manage 
to release arginine from skin proteins and lipids from the sebum (Scharschmidt and 
Fischbach, 2013). 
5.2.1 Skin microbiome composition 
The majority of skin bacteria belong to the three phyla of Actinobacteria, 
Firmicutes and Proteobacteria with the most common colonizers corynebacteria, 
propionibacteria and staphylococci (Costello et al., 2009; Human Microbiome Project, 
2012; Oh et al., 2016). However, different skin sites provide different 
microenvironments that largely vary in UV exposure, pH, temperature, moisture, 
sebum content and topography (Grice and Segre, 2011). Presence of different 
appendages such as sebaceous glands or sweat glands on different body sites 
largely shape the composition of the local microbiota. Consequently, the different skin 
sites can be broadly grouped into three categories: oily or sebaceous skin sites such 
as the face, chest and back, moist skin sites such as the bend of the knee or the 
elbow and dry skin sites such as the forearm and palms. Additionally, sweat and 
sebum also contain antimicrobial molecules such as free fatty acids and AMPs that 
also shape the microbial composition.  
The first group to thoroughly analyze the composition of the skin microbiota used 
16S ribosomal RNA gene sequencing to identify the specific microbes present on the 
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skin (Costello et al., 2009). The results showed that in healthy adults, the composition 
of the skin microbiota was primarily dependent on the physiology of the individual 
skin sites (Figure 5). Interestingly, the composition of the microbiota was shown to 
vary less among different people than among different body sites of one individual. 
Furthermore, sebaceous sites displayed a low diversity in microbe composition and 
were dominated by propionibacteria, whereas moist skin sites were diversely 
colonized by staphylococci and corynebacteria. The most diversely colonized sites, 
however, were the dry skin sites which also exhibited a high abundance of Gram-
negative species and interestingly even exhibited a higher bacterial diversity than the 
gut (Costello et al., 2009). Later, the findings of Costello et al. (2009) that microbiota 
is mainly specific to skin site were confirmed by other groups using more advanced 
sequencing methods such as whole metagenomics sequencing (Findley et al., 2013; 
Grice et al., 2009; Oh et al., 2014; Oh et al., 2016). Additionally, metagenomic 
analysis revealed that bacteria make up around 75% of our skin microbiota while 
fungi are the least abundant with only 1%. In contrast to bacteria, fungi composition 
does not differ across different body sites (Findley et al., 2013; Oh et al., 2016). 
Moreover, around 15% of our skin microbiome consists of viruses which were shown 
to be specific to the individual and not to the body site (Oh et al., 2016). However, 
due to the lack of reference genomes among viruses and the disregard of RNA 
viruses by metagenomics a common virome among individuals has not been 
identified yet (Byrd et al., 2018; Hannigan et al., 2015; Oh et al., 2016). 
Initial skin colonization in newborns was shown to be undifferentiated across 
different body sites and depend on the delivery mode (Dominguez-Bello et al., 2010). 
However, site specificity was shown to be established already within the first two 
days after birth (Kennedy et al., 2017; Meylan et al., 2017). During puberty, the 
composition of the skin microbiota undergoes reconstruction. Increasing levels of 
hormones stimulate sebaceous glands to produce higher amounts of sebum which in 
turn favors the colonization of lipophilic bacteria such as propionibacteria. In line with 
this observation, the skin microbiota of infants is characterized by a high abundance 
of staphylococci (Oh et al., 2012). Therefore, AD, which is often associated with S. 
aureus colonization, is more prevalent in infants and declines with increasing age 
(Hanifin et al., 2007; Harrop et al., 2007). 
Furthermore, longitudinal sampling of skin microbiota of healthy adults 
demonstrated a high stability of microbial communities over a 2-year period, despite 
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constant environmental changes (Oh et al., 2016). Analysis at the strain level showed 
that this stability was determined by the maintenance of strains over time rather than 
by acquisition of new strains from the environment (Oh et al., 2016). Similarly, 
longitudinal studies of the gut microbiome also showed that individual strains persist 
over time (Faith et al., 2013; Schloissnig et al., 2013). Describing microbial 
communities at the strain level becomes especially important when conclusions on 
functional effects on the host are drawn. Virulence genes, for example, which are 
associated with biofilm formation or antibiotic resistance, were shown to be variably 
present in some S. epidermidis strains (Conlan et al., 2012; Meric et al., 2018). 
  
Figure 5: The skin microbiome composition is primarily dependent on the physiology of 
distinct skin sites. Adapted from (Byrd et al., 2018) 
Four sites are shown to represent the major microenvironments of the skin: forehead/glabella 
(sebaceous); antecubital fossa (moist); volar forearm (dry); and toe web space (foot). Pie charts 
represent the relative abundance of bacteria, eukarya and viruses among healthy adults. 
Additionally, major bacterial species are shown in relative abundance plots. Unlabeled colors 
represent other bacterial species 
5.2.2 Coagulase-negative Staphylococci 
Since microbial communities have been explored for a long time by using culture-
based techniques, microorganisms that thrive under common culture conditions such 
as staphylococci have been isolated more frequently than anaerobic growing 
bacteria. In humans, CoNS, especially S. epidermidis but also S. capitis, S. warneri, 
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S. hominis and S. lugdunensis, are the most frequently isolated skin commensals 
(Becker et al., 2014). S. epidermidis particularly colonizes moist areas such as the 
axillae, inguinal and perineal areas, anterior nares, conjunctiva and toe webs (Kloos 
and Musselwhite, 1975; Schleifer and Kloos, 1975). S. epidermidis does not produce 
aggressive toxins and many positive effects on skin homeostasis and immunity are 
attributed to this commensal (Stacy and Belkaid, 2019). 
Also S. lugdunensis was shown to be part of the normal skin flora where it 
particularly colonizes the inguinal and perineal regions, in the groin area, the axillae 
as well as the nail bed and the nose (Bieber and Kahlmeter, 2010; Zipperer et al., 
2016). S. lugdunensis can co-exist with other commensals on human skin such as S. 
epidermidis (Bieber and Kahlmeter, 2010; Gong et al., 2006), but intriguingly, nasal 
colonization by S. aureus or S. lugdunensis (Bieber and Kahlmeter, 2010; Zipperer et 
al., 2016) was shown to be mutually exclusive due to production of lugdunin, a 
peptide antibiotic (Zipperer et al., 2016). In fact, humans who are colonized by S. 
lugdunensis in the nose have a 6-fold lower risk of S. aureus carriage than individuals 
who are not colonized (Zipperer et al., 2016).  
However, due to their ubiquitous presence on human skin, commensals can also 
act as opportunistic pathogens: S. epidermidis, for example, frequently causes 
nosocomial infections mainly by colonizing medical devices where it causes catheter 
infections (Otto, 2009b). Additionally, S. epidermidis is one of the most frequent 
causes of sepsis in newborns (Dong et al., 2018). Nosocomial S. epidermidis 
infections are associated with methicillin resistance, inflammatory phenol-soluble 
modulin PSM-mec and polysaccharide production (Otto, 2009b). Recently, strain-
specific differences among commensal and invasive S. epidermidis strains were 
identified (Conlan et al., 2012; Meric et al., 2018): Using pangenome-wide 
association studies, sequence variations in 61 S. epidermidis genes associated with 
biofilm formation, cell toxicity, methicillin resistance and CXCL8 production were 
identified. In conclusion, enrichment of these putative virulence determinants among 
infectious isolates suggests that pathogenic strains are a subset of the commensal 
population. Additionally, S. aureus and S. epidermidis were shown to share genes 
involved in pathogenicity suggesting horizontal gene transfer (Meric et al., 2018). 
Similarly, S. lugdunensis is frequently associated with nosocomial infections (Argemi 
et al., 2019). In addition to nosocomial infections of medical devices, S. epidermidis 
was shown to increasingly colonize the skin of AD patients during flares (Byrd et al., 
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2017; Kong et al., 2012). However, whether S. lugdunensis colonization is also 
increased in AD patients remains to be evaluated. 
5.2.3 Staphylococcus aureus 
S. aureus is a Gram-positive bacterium that frequently colonizes the anterior 
nares of 30% of the human population (Wertheim et al., 2005). However, whether S. 
aureus should be considered a commensal is controversial, because at the same 
time, S. aureus is also a leading cause of endocarditis, bacteremia, osteomyelitis and 
skin and soft tissue infections (DeLeo et al., 2010). Since 80% of the S. aureus 
strains isolated from the blood of bacteremia patients match the strain present in their 
noses, the risk of developing S. aureus infections is higher for individuals that carry 
S. aureus in their nose (von Eiff et al., 2001; Weidenmaier et al., 2012). Eradication 
of nasal S. aureus significantly prevents the susceptibility for subsequent infections 
(Bode et al., 2010). Additionally, S. aureus is frequently isolated from inflamed and 
non-inflamed skin of AD patients where it further contributes to skin inflammation 
(see section 5.2.3.2) (Kong et al., 2012). 
Opposed to its CoNS counterparts, S. aureus was shown to express two 
coagulases, staphylocoagulase and von Willenbrand factor, which convert fibrinogen 
to fibrin resulting in blood clotting upon infection (Bjerketorp et al., 2002; Kinoshita et 
al., 2008). This reaction has been used for a long time to differentiate coagulase-
positive from negative staphylococci (Needham et al., 1945). Even though CoNS and 
S. aureus belong to the same genus their effects on the host are antagonistic. The 
success of S. aureus in being such a potent pathogen largely resides in the myriad of 
different surface-associated as well as secreted virulence factors it produces. 
Additionally, increasing usage of antibiotics gave rise to methicillin-resistant S. 
aureus strains (MRSA) which, by horizontal gene transfer, have acquired the mecA 
gene that confers resistance to the entire class of beta-lactam antibiotics (Hartman 
and Tomasz, 1984). Since the first clinical observation of MRSA in the 1960s 
different healthcare- and community-associated (HA-MRSA and CA-MRSA) MRSA 
stains have been observed across the globe (Turner et al., 2019). Due to 
asymptomatic nasal carriage, MRSA carriage of is often unrecognized which can 
become hazardous when these patients undergo surgery, immunosuppression or 
suffer from trauma which usually puts patients at a higher risk of developing invasive 
infections caused by endogenous pathogens (Wertheim et al., 2005). Among CA-
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MRSA strains the USA300 strain has risen to become the predominant strain for skin 
and invasive infections in North America (Diekema et al., 2014). In addition to 
methicillin resistance this strain is characterized by an increased presence of 
virulence genes (Planet, 2017).  
5.2.3.1 S. aureus virulence factors 
S. aureus produces a large array of virulence factors that contribute to its 
pathogenesis including many proteins that mediate adhesion to epithelial surfaces, 
destruction of host cells and tissues and virulence factors by which S. aureus 
circumvents elimination by the innate and adaptive immune system of the host 
(Guerra et al., 2017; Lowy, 1998) (Figure 6). In fact, the frequent recurrence of S. 
aureus infections demonstrates its ability to manipulate host immune responses. In 
the following the major virulence factors involved in S. aureus skin infection are 
described: 
S. aureus is equipped with a large array of surface proteins that mediate adhesion 
to epithelial surfaces: These proteins, referred to as microbial surface components 
recognizing adhesive matrix molecules (MSCRAMMs), specifically bind to skin 
epithelial surface proteins such as cytokeratin and loricrin (clumping factor B ClfB). 
Iron-regulated surface determinant A (IsdA) also promotes adhesion to loricrin, 
involucrin and cytokeratin. In addition, fibronectin-binding proteins A and B (FnBP) 
bind to the extracellular matrix proteins fibronectin (Foster and Hook, 1998; Patti et 
al., 1994). Interaction of fibronectin and integrin a5b1 can result in S. aureus invasion 
into epithelial cells (Foster et al., 2014). Moreover, S. aureus wall teichoic acid (WTA) 
binding to a type-F scavenger receptor, termed SR-F1 (SREC-I) in the nasal cavity 
plays an important role in nasal epithelial colonization (Wanner et al., 2017). 
Moreover, S. aureus secretes multiple different proteases that destroy the 
epithelial barrier and thus promote its colonization: The exfoliative toxin is a protease 
that degrades desmoglein, thereby disrupting the cell-cell contacts between 
keratinocytes (Amagai et al., 2000). S. aureus V8 protease induces severe 
transepidermal water loss in an epicutaneous mouse model by disturbing the stratum 
corneum (Hirasawa et al., 2010). S. aureus was shown to produce at least ten 
proteases which enables epidermal penetration. In addition, TH2 cytokines as well as 
absence of filaggrin, which are both hallmarks of AD, facilitated protease activity 
(Nakatsuji et al., 2016). Moreover, stimulation of endogenous keratinocyte proteases 
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further contributes to barrier destruction (Williams et al., 2017). In addition to 
epithelial barrier destruction, several of the S. aureus proteases can cleave and 
inactivate AMPs such as dermcidin or LL-37 (Lai et al., 2007; Sieprawska-Lupa et al., 
2004). In addition to proteases, secretion of other enzymes such as lipases can 
substantially contribute to S. aureus virulence (Nguyen et al., 2017). 
S. aureus also secretes many toxins that directly damage host cells (Otto, 2014): 
Panton-Valentine leukocidin, for example, damages leukocytes and keratinocytes 
(Chi et al., 2014). Moreover, S. aureus phenol-soluble modulins (PSMs) were 
shown to exhibit cytolytic activities at high concentrations (Peschel and Otto, 2013). 
PSMs exhibit pro-inflammatory properties at nanomolar concentrations (Peschel and 
Otto, 2013; Wang et al., 2007) by stimulating the formyl-peptide receptor 2 (FPR2), 
which is expressed by different types of immune cells and keratinocytes (Kretschmer 
et al., 2010). PSMa was shown to induce pro-inflammatory cytokines from 
keratinocytes and triggers skin inflammation in response to epicutaneous S. aureus 
infection (Nakagawa et al., 2017). PSMs are also used by S. aureus to lyse 
neutrophils and escape from killing upon phagocytosis (Geiger et al., 2012; 
Surewaard et al., 2013). One of the various S. aureus PSMs, the d-toxin, also 
contributes to skin inflammation by activating mast cells (Nakamura et al., 2013). 
Moreover, PSMs mobilize the release of lipoproteins from the S. aureus cytoplasmic 
membrane thereby promoting TLR2 activation (Hanzelmann et al., 2016).  
Additionally, several staphylococcal superantigens such as toxic shock 
syndrome toxin 1 (TSST-1) or staphylococcal enterotoxins (SE) also contribute to S. 
aureus pathogenesis during invasive infections as well as in AD (Skov et al., 2000; 
Spaulding et al., 2013). 
S. aureus is able to circumvent host innate defense by various escape 
mechanisms such as PRR signaling inhibition or resistance to host AMPs: The latter 
can be achieved, for example, by modification of cell wall molecules with positively-
charged amino acids and concomitant reduction of their affinity for AMPs (Peschel 
and Sahl, 2006). In order to escape TLR2 recognition, S. aureus secretes the TLR2 
antagonist staphylococcal superantigen-like protein 3 (SSL3) which prevents 
bacterial lipoproteins from binding to TLR2 (Koymans et al., 2015; Yokoyama et al., 
2012). Moreover, the S. aureus TIR domain protein blocks TLR2-mediated NF-κB 
signaling by sequestering MyD88 (Askarian et al., 2014). Additionally, skin exposure 
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to TLR2-6 lipopeptides from S. aureus was shown to suppress immune responses 
via induction of regulatory myeloid cells (Skabytska et al., 2014). Many S. aureus 
strains produce chemotaxis inhibitory proteins (CHIPS) and formyl peptide receptor-
like 1 inhibitory (FLIPr) and FLIPr-like protein all of which block formyl peptide 
receptors und thus inhibit leukocyte migration towards the site of infection (Bloes et 
al., 2015; de Haas et al., 2004). 
 
Figure 6: S. aureus virulence factors influencing epithelial tissue infection 
S. aureus produces a large array of virulence factors that contribute to its pathogenesis. Eclectic 
virulence factors such as proteins that mediate adhesion to epithelial surfaces, destruction of host 
cells and tissues as well as virulence factors by which S. aureus circumvents elimination by the 
innate and adaptive immune system of the host are described in this figure. CHIPS = chemotaxis 
inhibitory proteins; FLIPr = formyl peptide receptor-like 1 inhibitory; NET = neutrophil extracellular 
traps; AMP = antimicrobial peptide; MSCRAMM = microbial surface components recognizing 
adhesive matrix molecules; WTA = wall teichoic acid; PSM = phenol-soluble modulin; TIR = 
Toll/Interleukin-1 receptor; SSL3 = staphylococcal superantigen-like protein 3; TLR2 = Toll-like 
receptor 2; MyD88 = Myeloid differentiation primary response 88. 
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5.2.3.2 S. aureus and atopic dermatitis 
S. aureus skin colonization is highly associated with AD, with prevalence ranging 
from 30-100% depending on the age of the patient, sample size or sampling method 
(Tauber et al., 2016; Totte et al., 2016; Travers et al., 2010). Even though S. aureus 
has many surface proteins mediating adhesion to cytokeratin, loricrin, or involucrin of 
corneocytes in the stratum corneum (Weidenmaier et al., 2012), healthy skin does 
not appear to offer favorable conditions for persistent skin colonization whereas 
barrier disruption of murine skin increases S. aureus colonization (Wanke et al., 
2013). The reasons have remained elusive but it is likely that alterations in available 
nutrients and in skin microbiome composition associated with barrier defects are 
necessary for S. aureus to thrive on human skin (Kong et al., 2012). In a longitudinal 
study of pediatric individuals with AD it was shown that during the flares of AD S. 
aureus levels on the skin increase up to 100-fold compared to normal skin. 16S rRNA 
and whole genome sequencing showed that especially the relative abundance of 
staphylococci, mainly S. aureus but intriguingly also S. epidermidis, increased during 
the flare versus the pre- or post-flare state. Moreover, the increase in relative 
abundance of staphylococci correlated with a more severe disease (Byrd et al., 2017; 
Kong et al., 2012). On the strain level, it was shown that AD patients were colonized 
with heterogenous S. epidermidis strains, but S. aureus strains were clonal (Byrd et 
al., 2017).  
However, the key question to which answers are still conflicting remains: Does S. 
aureus cause AD or is S. aureus colonization a result of AD? Kennedy et al. (2017) 
describe a study of 50 infants who were swabbed at 4 different skin sites at 6 
different time points starting from birth to the age of 2 for a 2-year period. Using 16S 
rRNA gene sequencing they could not detect any significant increase in S. aureus 
colonization in the 10 infants that developed AD. Therefore, they concluded that the 
onset of AD precedes S. aureus colonization (Kennedy et al., 2017). By contrast, in a 
larger longitudinal study by Meylan et al. (2017) 149 infants, 36 of which developed 
AD, were sampled 7 times from birth to the age of 2 S. aureus was detected before 
the onset of AD. Prevalence of S. aureus at 3 months of age was significantly higher 
in infants who subsequently developed AD. Interestingly, prevalence of the CoNS S. 
hominis at 3 months of age was negatively correlated with subsequent AD 
development. Therefore, they conclude that CoNS contribute to skin homeostasis 
and protection against infection (Meylan et al., 2017). Further experimental evidence 
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that S. aureus can promote AD in susceptible individuals can be found in the 
literature: S. aureus was shown to stimulate keratinocytes to increase endogenous 
kallikrein protease activity which can damage the epithelial barrier by degradation of 
desmoglein-1 and filaggrin (Williams et al., 2017). Furthermore, epidermal 
penetration of S. aureus and concomitant induction of TH2 cytokines in murine skin 
and human skin equivalents was shown to correlate with S. aureus protease activity 
(Nakatsuji et al., 2016). Moreover, S. aureus lipopeptides where shown to induce the 
production of thymic stromal lymphopoietin (TSLP), which is considered an initiator of 
AD, in keratinocytes (Vu et al., 2010). In an epicutaneous mouse skin colonization 
model staphylococcal δ-toxin was identified as responsible for the enhanced IgE and 
IL-4 production and concomitant inflammation enhancement. Additionally, it was 
shown that S. aureus strains isolated from AD patients produce large amounts of δ-
toxin (Nakamura et al., 2013). Comparison of laboratory strains of S. aureus and 
clinical isolates from AD skin revealed that AD strains alter the T cell responses via 
Langerhans cells, resulting in TH2-shifted immune responses suggesting that the 
colonized AD strain on the skin surface itself may promote an AD-specific immune 
environment (Iwamoto et al., 2017). In line with this Byrd et al. (2017) showed 
biological effects of S. aureus at the strain level: topical colonization of mice with 
strains isolated from AD patients induced higher levels of skin inflammation and 
immune signatures characteristic for AD patients such as TH2 cell expansion (Byrd et 
al., 2017). By sequencing different S. aureus strains can be grouped into different 
clonal complex (CC) groups. Recent evidence shows that AD skin mainly harbors 
strains of the CC1 type while CC30 was associated with healthy individuals (Harkins 
et al., 2018b; Iwamoto et al., 2019; Rojo et al., 2014). Additionally, temporal variation 
in S. aureus CC type was linked to AD flares (Clausen et al., 2019). Further analyses 
of specific S. aureus strains of AD patients over time are needed to classify the 
characteristics of AD strains, leading to the discovery of the distinct markers of AD-
derived S. aureus. Additionally, reduced presence of AMPs such as LL-37, dermcidin 
and b-defensins also contribute to S. aureus colonization in AD patients (Rieg et al., 
2005; Yamasaki and Gallo, 2008). Ultimately, the TH2 cytokines IL-4 and IL-13 were 
shown to inhibit hBD2 and hBD3 gene expression (Hata et al., 2010). Taken 
together, these recent data support the hypothesis that S. aureus can promote AD 
development in susceptible individuals, however, the detailed mechanisms still 
remain elusive. 
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5.3 Functional effects of skin microbiota 
Members of the microbiota can directly and dynamically interact with pathogens 
and immune cells and the results of this interaction can define the pathogenesis and 
the outcome of a given infection. Before detection by PRRs and phagocytosis by 
leukocytes, pathogens are faced with a complex community of commensal 
microorganisms that reside on the skin and prevent pathogen colonization by multiple 
mechanisms: By inhabiting their various niches, commensals prevent pathogenic 
bacteria from gaining access to nutrients. This process is also referred to as 
colonization resistance and provides a first level of protection against invading 
pathogens (Buffie and Pamer, 2013; Sassone-Corsi and Raffatellu, 2015). On a 
second level, commensal bacteria can directly target pathogenic bacteria by 
producing bacteriocins or other peptide antibiotics that inhibit or kill competing 
bacteria. Ultimately, by triggering innate and adaptive immune responses in the host, 
commensal bacteria provide protection against invading pathogens. In the following 
the direct functional effects of CoNS on S. aureus skin infection as well as the effects 
of CoNS on skin immunity are described. 
5.3.1 Direct effects of skin microbiota on pathogens 
CoNS are frequent producers of lanthionine-containing bacteriocins, so called 
lantibiotics. These peptides contain the unusual amino acids lanthionine or 3-
methyl-lanthionine (Dischinger et al., 2014; Schnell et al., 1988; Willey and van der 
Donk, 2007). Lantibiotics such as nisin and (pro)-gallidermin are produced by the 
commensals Lactococcus lactis and S. gallinarum (Kellner et al., 1988). Additionally, 
it was recently shown that the skin commensal S. capitis also contains the gene 
cluster for gallidermin biosynthesis (Kumar et al., 2017). Interestingly, the amino acid 
sequence of gallidermin differs only in one amino acid from the S. epidermidis-
derived lantibiotic epidermin (Kellner et al., 1988). Both nisin and gallidermin share 
the same binding motif for the cell wall precursor lipid II and consequently both 
lantibiotics inhibit cell wall biosynthesis of a wide spectrum of Gram-positive bacteria 
including S. aureus (Breukink et al., 2003). Additionally, interaction of the cationic 
nisin with lipid II also induces pore formation and consequently disruption of ion 
gradients and the membrane of the anionic bacterial cell wall initiated by the high 
electrostatic forces (Brotz et al., 1998; Wiedemann et al., 2001). This pore consists of 
four lipid II molecules and eight nisin molecules (Hasper et al., 2004). The 22 amino 
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acid short gallidermin, however, is not able to span the membrane and hence its 
mode of action is primarily cell wall biosynthesis inhibition rather than pore formation. 
Apart from lipid II, gallidermin was additionally shown to interact with lipid I, III and IV 
resulting in not only murein but also wall teichoic acid synthesis inhibition (Muller et 
al., 2012). Due to the protective outer membrane Gram-negative bacteria are usually 
not affected by lantibiotics (Dischinger et al., 2014). In recent work of the group of 
Richard Gallo S. epidermidis and S. hominis strains were shown to produce novel 
lantibiotics that inhibit the growth of S. aureus. Interestingly, these lantibiotic-
producing strains were missing in AD patients. However, a single application of 
lantibiotic-producing S. epidermidis and S. hominis onto the skin of AD patients 
reduced the number of colonizing S. aureus within 24 hours demonstrating the 
translational potential of this probiotic strategy (Nakatsuji et al., 2017). 
Additionally, S. epidermidis was shown to inhibit S. aureus nasal colonization and 
biofilm formation via expression of the serine protease Esp (Iwase et al., 2010). It 
was shown that Esp degrades proteins of S. aureus essential for host cell adhesion 
(Sugimoto et al., 2013). Interestingly, pan genome sequencing of skin commensals 
revealed that most S. epidermidis strains contain the Esp gene gseA (Conlan et al., 
2012). However, it was shown that only a subset of S. epidermidis strains express 
the gseA gene under the tested conditions (Iwase et al., 2010). This discrepancy 
shows that simple presence of a gene does not guarantee protein expression. 
Whether expression is induced in the presence of S. aureus still needs to be 
determined. 
Similarly, S. lugdunensis inhibited both nasal and skin colonization of S. aureus 
via the production of lugdunin. Lugdunin is a thiazolidine-containing cyclic peptide 
antibiotic that is non-ribosomally synthesized and therefore belongs to a new class of 
bacteriocins. It displays potent antimicrobial activity against a wide range of Gram-
positive bacteria including S. aureus. Interestingly, humans that carry S. lugdunensis 
have a six-fold lower risk of S. aureus nasal carriage due to lugdunin production 
(Zipperer et al., 2016). Notably, S. aureus did not manage to develop escape or 
resistance mechanisms neither to Esp (Iwase et al., 2010) nor to lugdunin (Zipperer 
et al., 2016) after multiple generations raising a strong interest in these naturally-
derived antibiotics compared to conventional antibiotics in the treatment of S. aureus 
infections. 
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Moreover, S. epidermidis also produces phenol-soluble modulins (PSMy and 
PSMd) which exert antimicrobial activity against S. aureus (Cogen et al., 2010). 
Moreover, CoNS are able to control S. aureus colonization via interference with 
its quorum sensing signaling: In all staphylococci quorum sensing is achieved by 
the accessory gene regulator (agr) system. However, across staphylococci there is 
divergence within the agr locus resulting in different subtypes within and among 
species (Thoendel et al., 2011). In the following the S. aureus agr sytem type I is 
explained: Short autoinducing peptides (AIPs) are secreted by S. aureus and thereby 
the AIP density correlates with bacterial density. S. aureus senses the AIP 
concentration through the sensor histidine kinase AgrC which activates the 
downstream DNA-binding response regulator AgrA upon reaching a critical level of 
AIP. Subsequently, AgrA binds to the P2 promoter and induces the transcription of 
the agrBDCA operon resulting in a positive feedback regulation with transcription of 
the two-component system AgrCA as well as further AIP production and export 
through the exporter AgrBD. Moreover, AgrA binds to the P3 promoter and induces 
the transcription of RNAIII which is a global regulator of multiple S. aureus virulence 
factors (Le and Otto, 2015; Novick and Geisinger, 2008; Thoendel et al., 2011). It 
was shown that S. epidermidis can downregulate S. aureus virulence through 
quorum sensing interference (Otto et al., 2001; Otto et al., 1999). Screening for other 
CoNS that potentially inhibit transcription of the S. aureus agr operon, S. caprae, a 
bacterium that was only recently identified to colonize human skin (d'Ersu et al., 
2016) was shown to potently inhibit agr and RNAIII transcription (Paharik et al., 
2017). Furthermore, in an intradermal mouse skin injection model, S. caprae 
significantly reduced MRSA-induced tissue damage and bacterial burden by blocking 
S. aureus quorum sensing (Paharik et al., 2017). 
5.3.2 Effect of microbiota on skin immunity 
The finding that the microbiome largely influences skin immunity is nicely 
illustrated by the fact that germ-free mice display a defect in innate immunity (Goris et 
al., 1985). In the context of functional effect on skin immunity, S. epidermidis is the 
most studied commensal. Therefore, functional effects mostly of S. epidermidis on 
skin immunity are described in the following: 
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In undifferentiated keratinocytes secreted factors of S. epidermidis were shown to 
induce hBD2 and hBD3 expression in a TLR2-dependent manner (Lai et al., 2010). 
Later, the same group isolated a novel lipopeptide, named LP01, from S. epidermidis 
which induced AMP expression in keratinocytes and increased the capacity of 
keratinocyte cell lysates to kill S. aureus in a TLR2/CD36-p38-MAPK-dependent 
manner (Li et al., 2013). Moreover, our group showed that S. epidermidis can amplify 
the innate defense of keratinocytes against S. aureus (Wanke et al., 2011). Another 
S. epidermidis-derived lipopeptide (LP78), which has the same amino acid sequence 
as LP01 but possesses an N-terminal heneicosanoic acid group instead of a Lysine-
bound one, was shown to inhibit TLR3-mediated skin inflammation by activating 
TLR2 and inducing b-catenin phosphorylation (Li et al., 2019). Similarly, it was 
previously shown that upon injury keratinocytes require TLR3 signaling to induce 
inflammation and that S. epidermidis LTA-mediated activation of TLR2 antagonized 
the release of pro-inflammatory cytokines (Lai et al., 2009). Microbiota can also limit 
TSLP expression in mice with a defective skin barrier and thus prevent allergic skin 
inflammation (Yockey et al., 2013). 
A density of 1 million T cells per cm2 of skin (Clark et al., 2006) indicates that 
there are also commensal-specific effects on adaptive skin immunity: In germ-free 
mice or mice treated with broad spectrum antibiotics TH17 cell frequencies both in the 
skin and in the gut are severely reduced (Ivanov et al., 2008; Naik et al., 2012). In the 
gut mono-colonization with segmented filamentous bacteria restored the 
accumulation of TH17 cells and was associated with protection against 
gastrointestinal pathogens (Ivanov et al., 2009). Similarly, germ-free mice which 
failed to produce IL-17A and IFNg in abT cells in the skin failed to control Leishmania 
major skin infections. Here, recolonization with S. epidermidis restored dermal IL-17A 
and IFNg production and conferred protection against L. major. This development 
was shown to be independent from the gut microbiota but dependent on MyD88 and 
IL-1 signaling in the skin (Naik et al., 2012). Additionally, topical application of S. 
epidermidis onto mice was shown to induce IL-17A+ CD8+ T cell homing to the basal 
epidermis which enhances barrier immunity against Candida albicans infections by 
promoting IL-17A-mediated AMP production in interfollicular keratinocytes. They 
demonstrated that this commensal-driven CD8+ T cell response is antigen-specific 
and is mediated by a subset of CD103+ DCs by secretion of IL-1a. Whether this 
response also protects from S. aureus infection was not investigated (Naik et al., 
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2015). Later, enrichment of these CD8+ T cells was shown to be dependent on a 
specific clade (A20) of S. epidermidis which was previously shown to be highly 
prevalent on healthy human skin (Byrd et al., 2017; Linehan et al., 2018). 
Furthermore, S. epidermidis-specific CD8+ T cells express genes associated with 
wound healing and tissue repair which promoted and accelerated wound closure in a 
skin punch biopsy wounding model (Linehan et al., 2018). 
In addition to the group of Yasmine Belkaid, Scharschmidt et al. (2015) also 
reported an antigen-specific T cell response upon S. epidermidis skin colonization, 
which, however, led to immune tolerance: Colonization of neonatal mice with S. 
epidermidis resulted in antigen-specific Treg accumulation in the skin which also 
prevented aberrant skin inflammation. Using their model T cell antigen epi2W they 
found increased numbers of 2W-specific CD4+ Tregs both in the skin as well as in the 
skin-draining lymph nodes indicating that commensal antigens were recognized 
locally and systemically across an intact skin barrier (Scharschmidt et al., 2015). In 
their follow-up paper they analyzed the mechanisms that drive Treg migration into the 
skin. Given the fact that Treg accumulation and penetration of the hair shaft through 
the epidermis coincides around postnatal day 5 they hypothesized that the 
development of hair follicles, which represent an important niche for skin microbiota, 
drives Treg migration to the skin. Indeed, they showed that keratinocytes at the hair 
follicle express CCL20 which recruits CCR6+ Tregs into the skin (Scharschmidt et al., 
2017). 
Upon analysis of differential effects of S. epidermidis and S. aureus it was shown 
that monocyte-derived DC (moDC) exposure to the secretome of S. epidermidis 
resulted in high levels of IL-10 secretion whereas exposure to S. aureus secretome 
induced IFNg secretion, suggesting that skin commensals can counteract the 
inflammatory stimulus of pathogens. Moreover, S. aureus-primed moDCs induced 
CD4+ T cell proliferation whereas moDCs stimulated with S. epidermidis secretome 
did not (Laborel-Preneron et al., 2015). In line with these results, LTA derived from S. 
epidermidis or S. aureus elicited opposing cytokine profiles on murine DCs: While S. 
epidermidis elicited an IL-10-balanced immune profile, S. aureus induced high levels 
of IL-12p70 which resulted in IFNg and IL-17C production by DC-primed CD4+ T cells 
(Volz et al., 2018). In conclusion, S. epidermidis, as part of the skin microbiota, 
contributes to skin homeostasis by multiple different mechanisms ranging from 
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induction of AMP production to adaptive T cell responses. The protective 
mechanisms employed by S. epidermidis are illustrated in Figure 7. 
In addition to S. epidermidis, there are also other bacteria that have been 
associated with beneficial effects on the skin: For example, treatment of human 
moDCs or primary keratinocytes with Acinetobacter Iwoffi induced IL-10 production 
which reduced ovalbumin-induced allergic sensitization in an intradermal injection 
model (Fyhrquist et al., 2014). Moreover, in a placebo-controlled study lysate of the 
Gram-negative Vitreoscilla filiformis, which is home to thermal spring water, 
significantly reduced skin inflammation in AD patients. In a murine model of AD with 
NC/Nga mice the lysate of V. filiformis suppressed skin inflammation by inducing IL-
10 production in DCs in a TLR2/MyD88-dependent manner which resulted in Treg 
induction in vitro and suppression of effector T cell proliferation in skin draining lymph 
nodes (Volz et al., 2014). Similarly, treatment of moDCs with protein extract of 
Aquaphilus dolomiae, a Gram-negative bacterium isolated from Avene Spring water, 
induced IL-10 production and reduced S. aureus secretome-induced proliferation of 
CD4+ T cells (Martin et al., 2016). 
Moreover, microbiota where not only shown to control bacterial infections locally 
but also systemically and distally: Catabolism of tryptophan-containing dietary 
components to indole derivatives by commensals in the gut dampens the severity of 
inflammatory skin conditions (Di Meglio et al., 2014) through the aryl hydrocarbon 
receptor (Yu et al., 2018). In addition to that, commensal-derived peptidoglycan 
found in serum can also improve S. aureus killing by neutrophils (Clarke et al., 2010). 
Moreover, S. epidermidis was also shown to have beneficial effects on the 
development of ultraviolet-induced skin cancer (Nakatsuji et al., 2018). Apart from 
influencing skin immunity, a comparison of the skin transcriptomes of germ-free mice 
and SPF mice revealed that the microbiota also regulates epidermal differentiation 
(Meisel et al., 2018). 
In conclusion, commensals exhibit diverse effects on the skin which we are only 
beginning to understand. However, the effects of microbiota were also shown to be 
context-dependent: For example, repeated topical exposure to Corynebacterium 
accolens or its membrane derivative mycolic acid resulted in the expansion of a 
defined subset of IL-17+ gdT cells which was non-inflammatory during homeostasis. 
In the context of a high fat diet, however, these T cells promoted skin inflammation 
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(Ridaura et al., 2018). Moreover, in addition to S. aureus also levels of S. epidermidis 
were shown to be increased during the flares of AD (Kong et al., 2012). But until 
today it is unclear whether S. epidermidis contributes to inflammation or whether its 
levels rise to prevent S. aureus from colonizing. 
 
Figure 7: The miscellaneous functional effects of S. epidermidis 
The commensal S. epidermidis exhibits diverse functional effects on host skin immunity: By 
directly targeting S. aureus it can shape pathogen skin colonization. Additionally, S. epidermidis 
can interact with keratinocytes and other immune cells of the skin to counteract inflammation, 
infection, and cancer. Eclectic functional effects of S. epidermidis are shown in this figure. DC = 
dendritic cell; T reg = reulatory T cell; IL-10 = Interleukin-10; IL-1a = Interleukin-1a; PSM = 
Phenol soluble modulin; agr = accessory gene regulator; hBD = human beta defensin; TLR = 
Toll-like receptor; LP = Lipopeptide; 6-HAP = 6-N-hydroxyaminopurine. 
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5.3.3 Outlook: applications of skin microbiota 
Conventional therapeutic strategies in AD have sought to target S. aureus by 
using broad-spectrum oral or topical antibiotics such as mupirocin as well as 
antiseptics. However, these strategies rarely prevent long-term S. aureus 
colonization and lack specificity. As a result, antibiotic treatment destroys the 
beneficial microbiota and at the same time selects for antibiotic-resistant S. aureus 
strains (Harkins et al., 2018a). In conclusion, current treatment options display a 
limited solution for patients suffering from staphylococcal super-infections and more 
targeted therapies are needed to combat S. aureus infections in AD patients. Since 
S. aureus frequently evolves antibiotic resistance (DeLeo et al., 2010) and vaccine 
development is nearly impossible (Jansen et al., 2013; Proctor, 2012) the idea of 
using microbiota to eradicate pathogens has been receiving a lot of attention. 
Microbiota can be harnessed to combat pathogen infections both by producing 
bacteriocins and by activating the immune system (Pamer, 2016). Promising 
strategies involve transplantation of microbiota from healthy donors to diseased 
which has already successfully been done in the gut in patients suffering from 
relapsing Clostridium difficile infections (van Nood et al., 2013). Therefore, unique 
antimicrobials or strains from healthy skin need to be identified and topically 
transplanted onto the skin of AD patients. Meylan et al. (2017) already show that 
presence of CoNS such as S. hominis during infancy can be protective against AD 
(Meylan et al., 2017). In line with this, many CoNS produce peptide antibiotics which 
specifically kill S. aureus and thus provide protection: S. epidermidis and S. hominis 
were shown to produce novel lantibiotics which were missing in AD patients. A single 
application of these lantibiotic-producing staphylococci onto the skin of AD patients 
significantly reduced the number of S. aureus colonizing the skin demonstrating the 
translational potential of this probiotic strategy (Nakatsuji et al., 2017). Similarly, 10 
adult and 5 pediatric patients were enrolled in an open-label phase I/II safety and 
activity trial. Treatment with the commensal Roseomonas mucosa was associated 
with significant decreases in disease severity and S. aureus burden in AD patients 
(Myles et al., 2018).  
Interestingly, a low diversity of the gut microbiome during the first month of life 
was associated with subsequent development of AD (Abrahamsson et al., 2012; 
Ismail et al., 2012; Wang et al., 2008). In line with this, probiotic supplementation of 
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the gut microbiome has beneficial effects on the development of AD (Foolad et al., 
2013): 
The adjuvant effect of the microbiota was not only shown during pathogen 
infection but also during cancer therapy: For example, cyclophosphamide, an anti-
cancer immunomodulatory agent, leads to intestinal damage and concomitant 
microbial translocation which was shown to promote TH17, TH1 and Tgd cell 
responses that collectively contribute to the anti-tumor response (Daillere et al., 
2016). In addition, upon disruption of the gut microbiota via antibiotic treatment or in 
germ-free mice myeloid-derived cells responded poorly to tumor therapy and the 
capacity of the host to control subcutaneous tumors was shown to be impaired (Iida 
et al., 2013). Moreover, immune checkpoint blockade of cytotoxic T lymphocyte-
associated antigen 4 (CTLA-4) leads to inhibition of regulatory pathways in T cells 
and thus enhances anti-tumor activity dependent on distinct bacteroides species. 
Fecal transplant of human gut microbiota to mice confirmed that that treatment of 
melanoma with CTLA-4 antibodies favored the outgrowth of B. fragilis with anti-
cancer properties (Vetizou et al., 2015).  Furthermore, in mice bifidobacteria alone 
improved melanoma outgrowth to the same degree as PD-L1 antibody therapy and 
combination nearly abolished tumor growth in a dendritic cell CD8+ T cell mediated 
manner (Sivan et al., 2015). 
In conclusion, commensals control various aspects of immunity both locally and 
systemically. Uncovering the single pathways and mechanisms and identifying more 
commensal-derived molecules involved in these processes bears huge potential for 
the further development of commensal adjuvants that can be applied in the treatment 
of infectious diseases, autoimmune diseases as well as cancer.  
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6 Aim of this Thesis 
Our skin is constantly exposed to a large number of pathogens, while at the same 
time commensal bacteria are ubiquitously colonizing. While CoNS are among the 
main colonizers, S. aureus is rarely found on healthy human skin. However, S. 
aureus is frequently isolated from the inflamed lesional skin of AD patients where it 
further causes skin inflammation and contributes to the worsening of the disease 
(Schittek, 2011). Thereby, overabundance of S. aureus during AD flares is 
associated with a loss of skin microbiome diversity indicating that skin commensal 
bacteria shape S. aureus skin colonization (Kong et al., 2012). Therefore, the overall 
aim of this thesis was to investigate the functional effects of two skin commensals, S. 
epidermidis and S. lugdunensis, on S. aureus skin colonization. Additionally, this 
work also aimed at understanding how skin inflammation contributes to initial S. 
aureus skin colonization. 
The specific aims for the included publications were the following: 
Accepted Publication I: The aim of this publication was to assess whether S. 
epidermidis protects primary human keratinocytes and mouse skin from S. aureus 
skin colonization both during skin homeostasis (i) and during skin inflammation (ii) 
induced by tape-stripping. 
Accepted Publication II: The aim of this publication was to (i) assess whether S. 
lugdunensis-derived lugdunin induces skin protection similar to S. epidermidis and 
whether it affects the S. epidermidis-induced protective effect as well as to (ii) 
analyze whether lugdunin is able to induce an innate immune response in the skin. 
And finally, (iii) to investigate whether lugdunin can cooperate with other commensal- 
and host-derived AMPs to kill S. aureus. 
Accepted Publication III: The aim of this publication was to evaluate (i) the 
diverse functional implications of keratinocytes in cutaneous S. aureus infection as 
well as (ii) their role as central players in microbial immune defense.  
Accepted Manuscript I: The aim of this manuscript was to assess how skin 
inflammation increases S. aureus skin colonization. Therefore, the specific aims were 
to (i) compare the immune cell composition in healthy mouse skin to tape-stripped 
skin and to (ii) analyze the role of the resulting increased number of neutrophils in the 
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skin in S. aureus skin colonization. Additionally, (iii) the mechanism how neutrophils 
enhance S. aureus skin colonization needed to be investigated. Finally, (iv) it needed 
to be analyzed whether S. epidermidis modulates neutrophil recruitment in mouse 
skin.  
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7 Results and Discussion 
Epithelial barrier tissues such as the skin are constantly exposed to an immense 
number of potential pathogens, while at the same time commensal bacteria are 
allowed to colonize. In this complex ecosystem CoNS are among the main colonizers 
(Grice and Segre, 2011). Thereby, S. epidermidis is the most frequently isolated skin 
commensal in humans (Grice and Segre, 2011; SanMiguel and Grice, 2015). S. 
aureus, however, can only rarely be found on healthy human skin, but was found to 
asymptomatically colonize the nose of 30% of the human population (Wertheim et al., 
2005). Additionally, S. aureus is frequently isolated from the skin of AD patients 
where it further contributes to skin inflammation which consequently leads to disease 
worsening (Schittek, 2011). Interestingly, overabundance of cutaneous S. aureus 
especially during AD flares is associated with a loss of microbiome diversity 
indicating that the skin microbiome shapes S. aureus skin colonization (Kong et al., 
2012). 
In this work it was investigated how the two CoNS of our skin microbiota, S. 
epidermidis and S. lugdunensis, can protect the skin from S. aureus colonization 
during homeostasis (Accepted Publication I, II and Accepted Manuscript I). 
Additionally, it was investigated whether and how skin inflammation contributes to S. 
aureus colonization (Accepted Manuscript I) and how S. epidermidis shapes S. 
aureus colonization in an inflammatory environment (Accepted Publication I). 
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7.1 S. epidermidis protects the skin against S. aureus colonization 
As the most frequently isolated skin commensal, S. epidermidis was shown to 
contribute to skin homeostasis and prevent pathogen colonization by multiple 
mechanisms (see section 5.3). For example, it has previously been shown that S. 
epidermidis can block S. aureus virulence factor expression by cross-inhibition of the 
agr-operon (Otto et al., 1999) or it can prevent S. aureus skin colonization by the 
production of a protective lipopeptide (Lai et al., 2010; Li et al., 2013) or by producing 
PSMs which can cooperate with host-derived AMPs to kill pathogens (Cogen et al., 
2010). Additionally, it was previously shown by our group, that S. epidermidis is able 
to amplify the innate immune response of primary human keratinocytes (PHKs) 
(Wanke et al., 2011). However, the effect of S. epidermidis on S. aureus colonization 
on healthy versus inflamed skin has not been investigated. In our study we analyzed 
the influence of S. epidermidis on S. aureus skin colonization both in vitro and in vivo 
by using either PHKs or an epicutaneous mouse skin infection model with healthy 
skin or during skin inflammation induced by tape-stripping (Burian et al., 2017; 
Wanke et al., 2013; Zipperer et al., 2016). 
In the in vitro infection model differentiated PHKs were pretreated with either living 
S. epidermidis 1457 (multiplicity of infection (MOI) = 30) for 2 hours or S. epidermidis-
conditioned medium (CM) for 24 hours. Subsequently, cells were infected with the S. 
aureus strains USA300 or SA113 (MOI = 30) for 1.5 hours and the number of colony 
forming units (CFUs) that adhered to PHKs and invaded PHKs were analyzed. The 
data presented in Accepted Publication I, Figure 1 demonstrate that S. epidermidis 
significantly protects PHKs against S. aureus adhesion and invasion. Interestingly, 
this protective effect could be observed both by using live S. epidermidis and S. 
epidermidis-CM, indicating that S. epidermidis-secreted factors are responsible for 
immune conditioning of the epithelial barrier. Of note, usage of CM derived from other 
skin-derived and clinical S. epidermidis strains result in a similar reduction of S. 
aureus colonization. However, reduced S. aureus colonization of PHKs was neither 
observed upon pretreatment with S. aureus CM itself nor upon pretreatment with CM 
derived from other commensal Staphylococci. Of note, CM of Corynebacterium 
pseudodiphteriticum and S. haemolyticus induced a slight, however not significant, 
reduction in S. aureus colonization. In summary, these data indicate that the 
observed protective effect is a general effect that can be attributed to S. epidermidis. 
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To examine whether S. epidermidis also exerts this protective effect in vivo we 
used an epicutaneous mouse skin colonization model: Here, 15 µL of live S. 
epidermidis bacterial cells (109), S. epidermidis CM or PBS as a control was 
epicutaneously applied 24 hours before S. aureus USA300 (108) application on the 
shaved dorsal skin of C57BL/6 mice by using Finn Chambers® (Smart Practice). 24 
hours after S. aureus application the number of surface-attached CFUs as well as of 
CFUs located in deeper skin tissue was determined. The data in Accepted 
Publication I, Figure 2 demonstrate that pretreatment of mouse skin both with live S. 
epidermidis and with S. epidermidis CM results in significantly lower S. aureus 
colonization compared to control mice indicating that also in vivo S. epidermidis and 
its secreted factors induce a protective mechanism which prevents S. aureus from 
colonizing. 
Since S. aureus is frequently isolated from the inflamed skin of AD patients 
(Tauber et al., 2016; Totte et al., 2016; Travers et al., 2010) and we could already 
show that induction of skin inflammation by tape-stripping increases S. aureus 
colonization in vivo (Wanke et al., 2013) we proceeded to investigate whether S. 
epidermidis also exerts its protective capacities in an inflammatory environment in 
vivo. Therefore, we induced skin inflammation by repeatedly (7x) pulling off tape from 
the shaved dorsal skin of mice just before application of S. epidermidis, S. 
epidermidis CM or PBS. Interestingly, upon induction of skin inflammation the 
protective effect of S. epidermidis CM was lost whereas the effect was completely 
reversed upon pretreatment with live S. epidermidis which even significantly 
increased S. aureus skin colonization. Since this significant increase was only 
observed upon pretreatment with living S. epidermidis and not with CM these results 
indicate that here, a cell-bound compound of S. epidermidis is responsible for 
enhanced S. aureus colonization during skin inflammation. 
To summarize, in Accepted Publication I we show that S. epidermidis as a 
member of the skin microbiota induces a protective effect on S. aureus skin 
colonization both in vitro on keratinocytes and in vivo during homeostasis. However, 
S. epidermidis-induced skin protection is dependent on the integrity of the epithelial 
barrier and is completely reversed by the induction of skin inflammation by tape-
stripping. Considering previous data that show that S. epidermidis can amplify the 
innate immune response of human skin (Wanke et al., 2011) we conclude that skin 
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commensals create a protective environment by immune conditioning the healthy 
epithelial surface towards a protective immune response. However, skin inflammation 
itself can promote pathogen colonization and infection which might result in the 
suppression of the protective mechanism of skin commensals. 
In the following work (section 7.2), it was analyzed whether the peptide antibiotic 
lugdunin derived from S. lugdunensis, another skin commensal, is equally well able 
to induce skin protection against S. aureus and whether lugdunin influences the S. 
epidermidis-induced protective effect. The work presented thereafter (section 7.3) 
aims at revealing the mechanisms how skin inflammation contributes to enhanced S. 
aureus colonization and presents a possible mechanism why S. epidermidis is unable 
to protect against S. aureus during skin inflammation. 
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7.2 Lugdunin amplifies innate immune responses in the skin in 
synergy with host- and microbiota-derived factors 
S. lugdunensis is most frequently found in humans on the skin in the inguinal and 
perineal areas, the axilla, as well as in the nail bed and the nose (Bieber and 
Kahlmeter, 2010; Zipperer et al., 2016) and is considered a part of the normal human 
skin microbiota. S. lugdunensis can co-exist with other commensals on human skin 
such as S. epidermidis (Bieber and Kahlmeter, 2010; Gong et al., 2006), but 
intriguingly, nasal colonization by S. aureus or S. lugdunensis (Bieber and Kahlmeter, 
2010; Zipperer et al., 2016) was shown to be mutually exclusive (Zipperer et al., 
2016). In fact, humans who are colonized by S. lugdunensis in the nose have a 6-fold 
lower risk of S. aureus carriage than individuals who are not colonized (Zipperer et 
al., 2016). However, the total number of S. lugdunensis in the noses of carriers is 
considerably low compared to the absolute numbers of other commensals colonizing 
the nasal epithelium (Zipperer et al., 2016). Mutual exclusiveness was shown to 
result from the production of lugdunin, a novel peptide antibiotic produced by S. 
lugdunensis (Zipperer et al., 2016). While bacteria from the human microbiota have 
long been found to produce bacteriocins acting against closely related bacteria 
(Dobson et al., 2012; Kommineni et al., 2015), lugdunin represents the founding 
member of a new class of cyclic thiazolidine-containing peptide antibiotics (Zipperer 
et al., 2016). It exhibits high antimicrobial activity in the micromolar range against a 
wide range of Gram-positive bacteria including methicillin-resistant S. aureus 
(MRSA), vancomycin-resistant Enterococcus isolates and Bacillus subtilis. 
7.2.1 Lugdunin amplifies S. epidermidis-induced skin protection against S. 
aureus  
Similar to the protective effect induced by S. epidermidis presented in Accepted 
Publication I (Burian et al., 2017), our groups previously demonstrated that lugdunin 
effectively reduces S. aureus epithelial colonization in rodents and humans (Zipperer 
et al., 2016). In contrast to S. epidermidis application which was administered before 
S. aureus colonization, lugdunin was applied one and two days after S. aureus 
colonization in these experiments (Zipperer et al., 2016). Obviously, the direct 
bactericidal effect of lugdunin led to S. aureus killing. However, considering the fact 
that human nasal colonization with either S. lugdunensis or S. aureus was shown to 
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be mutually exclusive (Zipperer et al., 2016), even though absolute numbers of S. 
lugdunensis were considerably low, we investigated whether there might be an 
additional mechanism mediated by immune conditioning of epithelial cells by 
lugdunin. Therefore, we first tested whether pretreatment of PHKs or mouse skin with 
lugdunin also results in reduced S. aureus colonization by using the described 
models from Accepted Publication I (section 7.1). Indeed, pretreatment of PHKs with 
lugdunin alone at concentrations of 2 µM and above significantly reduced the number 
of adhering S. aureus (Accepted Publication II, Figure 1a) and concurrently, 
pretreatment of mouse skin with lugdunin alone resulted in a slight, however not 
significant, reduction of colonizing S. aureus (Accepted Publication II, Figure 1b). 
Strikingly, lugdunin-mediated reduction of S. aureus colonization was significantly 
enhanced both in vivo and in vitro upon combining lugdunin with S. epidermidis CM 
(Accepted Publication II, Figure 1a+b). In conclusion, these data indicate that 
lugdunin is not only able to directly kill S. aureus but can also sensitize keratinocytes 
towards a protective response against S. aureus skin colonization which can even be 
potentiated by secreted factors produced by S. epidermidis. 
7.2.2 Lugdunin induces LL-37 and CXCL8 in keratinocytes 
To elucidate the mechanism of the lugdunin-induced protective response, we 
analyzed whether lugdunin is able to induce the expression of AMPs or pro-
inflammatory cytokines in PHKs, either alone or in combination with S. epidermidis 
CM. PHKs express a basal level of hBD-1, hBD-2 and hBD-3 as well as LL-37 and 
RNase7 (Schroder and Harder, 2006) and our groups previously demonstrated that 
S. epidermidis CM is able to induce hBD-1, hBD-2 and LL-37 expression  (Wanke et 
al., 2011) which was confirmed in this work (Accepted Publication II, Figure 1c). 
Interestingly, lugdunin treatment of PHKs alone significantly induced LL-37 
expression and release in a dose-dependent manner as well as expression of hBD-1 
and RNase7 (Accepted Publication II, Figure 1c and Figure S1a+b). Surprisingly, 
combined treatment of PHKs with S. epidermidis CM and lugdunin did not amplify but 
abolished the effect of S. epidermidis CM on the induction of the respective AMPs, 
except for LL-37 (Accepted Publication II, Figure 1c). Next, we analyzed, whether 
lugdunin is able to induce the expression and secretion of different pro-inflammatory 
cytokines and chemokines in PHKs. Interestingly, increasing lugdunin-concentrations 
up to 3 µM specifically induced expression and release of CXCL8 in PHKs (Accepted 
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Publication II, Figure 1d+e and Figure S1c), while higher concentrations did not 
induce CXCL8 production (Accepted Publication II, Figure 1e and Figure S1c). 
Conversely, expression and release of LL-37 increased with higher lugdunin 
concentrations (Accepted Publication II, Figure S1a+b). Lugdunin-induced LL-37 and 
CXCL8 secretion was further confirmed by topical application of lugdunin on a human 
3D skin equivalent (Accepted Publication II, Figure S1d). Additionally, in order to 
confirm that lugdunin induces LL-37 expression in keratinocytes also in vivo we 
performed immunohistochemical stainings of mouse skin sections upon epicutaneous 
application of lugdunin and S. lugdunensis. Indeed, keratinocytes in the epidermis 
and at the hair follicles, which were also the locations of S. lugdunensis colonization 
(Accepted Publication II, Figure S2d), showed a positive LL-37 staining (Accepted 
Publication II, Figure S1e).  
In order to exclude potential lipopeptide contamination of purified lugdunin 
(Hashimoto et al., 2006) we compared CXCL8 induction in PHKs by synthetic and 
natural lugdunin. However, treatment of PHKs both with synthetic and natural 
lugdunin resulted in similar CXCL8 expression levels. In fact, the potential of lugdunin 
to induce CXCL8 seems to be dependent on its direct antimicrobial activity since the 
non-antimicrobial N-Acetyl-lugdunin (Schilling et al., 2019) did not induce CXCL8 
expression in PHKs (Accepted Publication II, Figure S1f). In conclusion, antimicrobial 
activity of lugdunin with its original thiazolidine heterocycle building block seems to be 
crucial for innate immune activation in keratinocytes. 
Notably, lugdunin was also able to induce CXCL8 expression in primary human 
nasal and tracheal epithelial cells (HNEpCs and HTEpCs) as well as in peripheral 
blood mononuclear cells (PBMCs) (Accepted Publication II, Figure S1g-i), however, 
with a much lower efficacy compared to PHKs. Of note, basal protein levels of 
CXCL8 in these cells were already higher compared to PHKs and could not be 
further increased by lugdunin treatment (Accepted Publication II, Figure 1f). In 
HNEpCs and HTEpCs, but not in PHKs and PBMCs, lugdunin was also able to 
induce the release of IL-1a (Accepted Publication II, Figure 1d+g), another important 
pro-inflammatory cytokine involved in epithelial barrier immunity (Naik et al., 2015; 
Naik et al., 2012). Of note, the observed induction of pro-inflammatory cytokines in 
the different cell types is not a result of possible cytotoxic features of lugdunin since it 
did not display any cytotoxicity on the cell types used in this study (Accepted 
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Publication II, Figure S1j) nor on primary human neutrophils, erythrocytes or the 
human monocytic cell line HL60 (Zipperer et al., 2016).  
In summary, our data indicate that lugdunin is able to induce expression of LL-37 
and pro-inflammatory cytokines in PHKs which might modulate the response of PHKs 
towards S. aureus skin colonization. Additionally, the type of immune response 
induced by lugdunin is cell-type specific, which might correlate with the different sites 
of S. lugdunensis colonization observed in humans (Bieber and Kahlmeter, 2010). 
7.2.3 Lugdunin-induced cytokine production is TLR/MyD88-dependent 
Since CXCL8 expression can be induced in PHKs and other cell types by 
activation of TLR2 (Fournier, 2012) we analyzed the potential role of TLR2 in 
lugdunin-induced CXCL8 release by using HEK293-TLR2 cells, which were 
transfected with a TLR2 containing plasmid leading to surface expression of TLR2 as 
well as HEK293 cells as a control, which do not express TLR2 (Hanzelmann et al., 
2016). Pam2Cys and Pam3Cys positive control treatments of HEK293-TLR2 cells 
resulted in increased CXCL8 expression and release in a TLR2-dependent way 
(Accepted Publication II, Figure S2). Indeed, also lugdunin resulted in CXCL8 
expression and release in a TLR2-dependent fashion, however, induction levels were 
1000 and 10-fold lower for protein and expression levels respectively compared to 
positive control treatments suggesting that lugdunin might be a weak TLR2 agonist or 
it might induce CXCL8 expression by an indirect TLR2 activating mechanism 
(Accepted Publication II, Figure 2a, b, Figure S2a+b). The latter could resemble the 
mechanism of staphylococcal PSMs which were shown to mobilize TLR2-activating 
lipopeptides from bacterial membranes (Hanzelmann et al., 2016). 
To further investigate the involvement of TLRs, we analyzed whether lugdunin is 
able to induce similar cytokines in murine skin as in PHKs. Therefore, we 
epicutaneously treated mouse skin with lugdunin or PBS as a control for 24 hours 
and determined the levels of pro-inflammatory cytokines in the skin (Accepted 
Publication II, Figure 2c-e, Figure S2c). Interestingly, we found that specifically IL-1a 
and MIP-2, the functional murine homologue of human CXCL8 (Zlotnik and Yoshie, 
2000), were induced by lugdunin (Accepted Publication II, Figure 2d+e). Levels of 
other cytokines such as MCP-1, GM-CSF, TNFa, IL-6, and IFNγ did not show 
significant differences compared to the control group except for the anti-inflammatory 
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cytokine IL-10 (Accepted Publication II, Figure S2c). Similar to LL-37 (Accepted 
Publication II, Figure S1e), immunohistochemical analyses of mouse skin sections 
confirmed that keratinocytes in the epidermis and at the hair follicles, the primary 
sites for S. lugdunensis colonization (Accepted Publication II, Figure S2d) produce 
MIP-2 (Accepted Publication II, Figure 2f). 
To analyze the importance of TLR- and MyD88-signaling in lugdunin-mediated 
cytokine induction, we additionally analyzed cytokine levels upon lugdunin treatment 
in the skin of mice deficient for MyD88 (MyD88-ko) or for TLR2, TLR3, TLR4, TLR7 
and TLR9 (5xTLR-ko). However, expression of most cytokines was not significantly 
different upon lugdunin treatment compared to WT control mice (Accepted 
Publication II, Figure S2c). Lugdunin was still able to induce IL-1a in the skin of 
MyD88-ko and 5xTLR-ko mice (Accepted Publication II, Figure 2d). Lugdunin-
induced MIP-2 induction, however, was completely impaired in mice lacking MyD88 
and reduced in 5xTLR-ko mice (Accepted Publication II, Figure 2e) thus confirming 
the in vitro data. In conclusion, these data show that lugdunin induces CXCL8/MIP-2 
in keratinocytes by a TLR/MyD88-dependent mechanism. 
7.2.4 Epicutaneous lugdunin recruits phagocytic cells 
Keratinocytes express several pattern recognition receptors such as TLR2, which 
recognizes S. aureus lipopeptides (Ryu et al., 2014). Activation of TLR2 leads to 
MyD88-dependent activation of NF-κB and other transcription factors, which 
subsequently induce the transcription of pro-inflammatory chemokines and cytokines 
such as CXCL8 and IL-1α as well as AMPs involved in cutaneous host defense 
against S. aureus (Ryu et al., 2014). While IL-1α was already shown to be induced in 
the skin by commensals where it substantially contributes to skin immunity (Naik et 
al., 2015; Naik et al., 2012), induction of CXCL8/MIP-2 expression in keratinocytes is 
an immediate and early pro-inflammatory response resulting in the recruitment of 
phagocytic immune cells to clear infections (Krishna and Miller, 2012; Miller and 
Modlin, 2007; Rot and von Andrian, 2004). Therefore, we analyzed the composition 
as well as the potential recruitment of immune cells into the skin of C57BL/6 WT, 
MyD88-ko and 5xTLR-ko mice 24 hours after epicutaneous treatment with lugdunin 
or PBS (Accepted Publication II, Figure 3a-d and Figure S3). In line with the 
lugdunin-induced MIP-2 induction, we found significantly enhanced recruitment of 
monocytes and neutrophils in the skin of mice treated with lugdunin which was 
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completely impaired in MyD88-ko and 5xTLR-ko mice (Accepted Publication II, 
Figure 3d). Additionally, we performed immunohistochemical staining of 
myeloperoxidase (MPO) in mouse skin sections demonstrating that epicutaneous 
application of both lugdunin and the lugdunin-producing S. lugdunensis results in 
recruitment of MPO-positive cells into the dermis (Accepted Publication II, Figure 3e). 
Percentages of live CD45+ cells (Accepted Publication II, Figure 3b), B, T, and NK 
cells as well as total CD11b+ cells and dendritic cells did not substantially differ from 
the PBS control upon treatment (Accepted Publication II, Figure 3c and Figure S3). 
Interestingly, macrophage levels were slightly reduced in percentage upon lugdunin 
treatment (Accepted Publication II, Figure 3c + Figure S3). Taken together, these 
results indicate that CXCL8/MIP-2 induction by lugdunin in mouse skin and in PHKs 
is mediated by a TLR/MyD88-dependent pathway in keratinocytes which leads to the 
recruitment of phagocytic innate immune cells such as monocytes and neutrophils. 
To conclude, clearance of pathogens by lugdunin-mediated recruitment of phagocytic 
cells complements its direct antimicrobial effects and thus provides an additional level 
of pathogen protection. 
7.2.5 Lugdunin amplifies innate immune response of keratinocytes 
Besides their bactericidal activity, host-derived AMPs have been shown to play a 
role in modulation of the innate immune defense (Schittek et al., 2008) and their 
expression was shown to be dysregulated in AD patients (Harder et al., 2010; Rieg et 
al., 2005; Schittek, 2011; Schittek et al., 2008; Yamasaki and Gallo, 2008). Since we 
showed that lugdunin is a very potent inducer of CXCL8 and LL-37 in PHKs, we 
asked whether other bacteria- and skin-derived AMPs are equally well able to induce 
CXCL8 expression in PHKs. We tested the bacteriocins nisin, gallidermin as well as 
the non-bactericidal pro-form pro-gallidermin and the human AMPs LL-37 and the 
dermcidin-derived peptides DCD-1 and DCD-1L. However, compared to the other 
AMPs and bacteriocins, lugdunin was especially potent in inducing CXCL8 
expression in PHKs leading to over 40-fold induction (Accepted Publication II, Figure 
4a). Only DCD-1 treatment resulted in a 10-fold induction of CXCL8 expression in 
PHKs. LL-37, nisin and (pro)-gallidermin, however, were not able to induce CXCL8 
expression in PHKs. 
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Since we have already shown that skin protection against S. aureus is amplified 
when lugdunin is combined with S. epidermidis CM, we next investigated the 
potential of lugdunin and the other peptides to induce CXCL8 when combined with S. 
epidermidis CM. S. epidermidis CM alone was equally well able to induce CXCL8 
expression in PHKs as lugdunin. Interestingly, CXCL8 induction could be highly 
amplified by the combination of S. epidermidis CM and lugdunin from 40-fold to over 
1000-fold (Accepted Publication II, Figure 4a). This effect was specific for lugdunin 
since all other peptides did not significantly affect S. epidermidis-induced 
upregulation of CXCL8 expression in PHKs. Noticeable, gallidermin completely 
blocked S. epidermidis CM-induced CXCL8 expression in PHKs (Accepted 
Publication II, Figure 4a). This observation is in line with recent data from Bengtsson 
et al. (2018) who found that gallidermin abolishes Staphylococci-induced release of 
CXCL8 and IL-6 in primary human dermal fibroblasts by which it may counteract a 
potentially harmful inflammatory process (Bengtsson et al., 2018). 
Since lugdunin induced the expression of LL-37 in PHKs (Accepted Publication II, 
Figure 1c), we additionally investigated CXCL8 expression in PHKs upon 
combinational treatments of lugdunin and the other bacterial antimicrobials with the 
human AMPs LL-37 or DCD-1L and DCD-1. Pam2Cys, IL-1a, or S. epidermidis CM 
treatment served as positive controls. As shown already in Accepted Publication II, 
Figure 4a, lugdunin treatment alone was already very potent in inducing CXCL8 
expression in PHKs which could not be further amplified by combined treatments 
(Accepted Publication II, Figure 4b). 
Furthermore, DCD-1 single treatments as well as combinations that involved 
DCD-1 or DCD-1L significantly induced CXCL8 expression. These results are in 
agreement with Niyonsaba et al. (2009) who showed that DCD-1L activates NF-kB 
signaling in human keratinocytes and leads to the release of TNFα, CXCL8, 
interferon-inducible protein 10 (CXCL10) and macrophage inflammatory protein-3α 
(CCL20) (Niyonsaba et al., 2009b). Additionally, it was shown that dermcidin 
treatment of PBMCs induces the release of TNFα (Wang et al., 2016). DCD peptides 
are secreted by eccrine sweat glands where they can be transported to the skin 
surface and serve as a constant antimicrobial shield and are thus constitutively 
present on human skin (Rieg et al., 2004; Schittek et al., 2001) (Accepted Publication 
II, Table 1). Thus, being constantly present on the skin surface, our results suggest 
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that dermcidin peptides are able to increase the innate immune defense on the skin 
depending on the available commensal- or pathogen-derived peptide antibiotics. 
These data indicate that lugdunin is a very potent immune modulator of the skin that 
acts in concert with other microbiota-derived modulating factors. 
In order to exclude that CXCL8 induction results from cytotoxicity of the used 
peptides we complement our previous results that showed that lugdunin does not 
display cytotoxicity on host cells (Accepted Publication II, Figure S1j) by 
demonstrating that none of the used peptides in this study show host cell cytotoxicity 
(Accepted Publication II, Figure S4). These results conform to data reported by other 
groups that showed that lantibiotics usually display low cell cytotoxicity (Maher and 
McClean, 2006). 
7.2.6 Lugdunin acts synergistically with host-derived AMPs 
In addition to its immune modulating activity lugdunin was discovered for its ability 
to directly kill S. aureus (Zipperer et al., 2016). Regarding its mode of action, it was 
shown that bacterial cells exposed to lugdunin stopped incorporating DNA, RNA, 
protein or cell-wall precursors even at concentrations below the minimal inhibitory 
concentration (MIC) suggesting that lugdunin may lead to a rapid breakdown of 
bacterial energy resources (Zipperer et al., 2016). Recently it was shown that 
lugdunin equalizes the bacterial membrane potential by proton translocation 
(Schilling et al., 2019). Considering this antimicrobial activity as well as its ability to 
induce LL-37 and host defense signaling via TLRs/MyD88 in skin we speculated that 
lugdunin might potentially act in concert with other antimicrobial substances to 
increase S. aureus killing. In the following, we investigated the capacity of lugdunin, 
(pro)-gallidermin and nisin to kill S. aureus in cooperation with LL-37 and DCD-1 and 
DCD-1L. 
At first, we determined killing curves of the different human and bacterial AMPs 
for S. aureus USA300 in order to choose sub-bactericidal concentrations for 
subsequent synergistic studies (Accepted Publication II, Figure S5). Generally, in our 
experimental setting the efficiency of bacteriocins in S. aureus killing was higher than 
of the human AMPs. Although this work did not demonstrate a bactericidal effect of 
human AMPs on S. aureus at concentrations ranging from 1-15 µM, LL-37 has been 
described to inhibit S. aureus growth and kill S. aureus at 128 µg/mL (Niemirowicz et 
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al., 2016) and 19.3 µg/mL (Luo et al., 2017). This discrepancy to our data might 
result from using different bacterial strains: Usage of the highly virulent USA300 
strain which expresses virulence factors such as the mprf and dlt operon, both of 
which were shown to change the electric charge of the bacterial cell wall resulting in 
rejection of the positively charged LL-37, might impact susceptibility to LL-37. 
Moreover, exposure of S. aureus to different cationic AMPs was shown to induce 
further upregulation of mprf or dlt (Otto, 2010; Ryu et al., 2014). Additional described 
resistance mechanisms of S. aureus are extracellular degradation of LL-37 via the 
proteases aureolysin and V8 protease and the AMP sensor system Aps, activation of 
which leads to changes in the bacterial surface charge via lysinylation of bacterial 
membrane lipids and D-alanylation of teichoic acids in the staphylococcal cell wall 
(Otto, 2009a; Ryu et al., 2014). Growth and viability of S. aureus were neither 
reduced by DCD-1(L) treatment at concentrations ranging from 1 μM to 15 μM. 
These results are supported by (Lai et al., 2007) describing a dermcidin 
concentration of around 10 μM as a sub-inhibitory concentration, whereas (Vuong et 
al., 2004) described an LD50 value of 5 μM. Nevertheless, it has to be noted that the 
antimicrobial activity of AMPs was shown to vary depending on the assay conditions. 
Human AMPs were shown to be less active against Staphylococci in the presence of 
trypticase soy broth medium which was used in our experimental setup (Schittek et 
al., 2001; Schwab et al., 1999). In medium resembling sweat dermcidin peptides 
were shown to exhibit antimicrobial activity against a broad spectrum of 
microorganisms including Staphylococci (Rieg et al., 2004; Vuong et al., 2004). 
Interestingly, in our experiments treatment with human AMPs increased S. aureus 
growth indicating the utilization of these peptides as nutrients. 
For our synergy studies we chose concentrations of 1-3 µM of lugdunin, human 
AMP concentrations of 1 and 2 μM and (pro-)gallidermin and nisin concentrations 
ranging from 0.4-0.8 μM. Combinations of the human AMPs DCD-1(L) and LL-37 
with sub-bactericidal concentrations of lugdunin or gallidermin and nisin resulted in 
enhanced S. aureus killing compared to the single treatments (Accepted Publication 
II, Figure 5a-c and Figure S6). Of note, the effect was specific for the active form of 
gallidermin since co-incubation with pro-gallidermin did not lead to antimicrobial 
activity (Accepted Publication II, Figure S5+6). Using CompuSyn software we 
analyzed potential synergistic effects of peptide combinations and calculated the 
combination indices for the indicated combinations. The activities of lugdunin and 
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gallidermin in combination with the human AMPs reached CI values below 1 
indicating synergistic activity of these peptides (Figure 5b). 
While expression of LL-37 can be increased by lugdunin in keratinocytes 
(Accepted Publication II, Figure S1a+b), dermcidin peptides are constantly present 
on human skin. Therefore, this work suggests that the presence of lugdunin-
producing S. lugdunensis on the skin locally increases LL-37 expression but also acts 
in cooperation with constitutively expressed host-derived AMPs. Interestingly, it was 
recently shown that during steady-state, in the absence of pathogens, commensals 
do not express bacteriocins (Ebner et al., 2018). Similarly, lugdunin expression is 
induced only upon direct contact of S. lugdunensis and S. aureus (Zipperer et al., 
2016). Thus, synergistic action of host- and bacteria-derived peptides can be 
employed when needed. 
To analyze whether the synergistic activity is a specific effect on S. aureus, we 
tested the spectrum of antimicrobial activity of lugdunin alone or in combination with 
DCD-1(L). Accepted Publication II, Figure S7 shows that the combined effect of 
lugdunin with DCD-1(L) could neither be observed for the Gram-positive skin 
commensal S. epidermidis or intestinal Enterococcus faecalis nor for the Gram-
negative bacteria Pseudomonas aeruginosa, Escherichia coli, or Proteus mirabilis. Of 
note, Bacillus subtilis was the only bacterial species tested besides S. aureus that 
was also susceptible to lugdunin and lugdunin/DCD-1(L) combinations (Accepted 
Publication II, Figure S7f). 
Additionally, we investigated whether the synergistic activity relies on the 
combined action of the peptides or whether one peptide is able to sensitize for 
bacterial killing by the other peptide. Therefore, we performed sequential incubation 
steps of the single peptides (Accepted Publication II, Figure 6). Single as well as 
simultaneous combination treatments were always included as controls. However, 
sequential treatment of S. aureus with the synergistically active peptide 
concentrations did not lead to S. aureus killing (Accepted Publication II, Figure 6). 
From these data we conclude that there is a synergistic activity of host- and bacteria-
derived peptides in S. aureus killing and that this synergistic effect seems to be 
dependent on simultaneous action of the bioactive peptides indicating that either pre-
formed complexes of the peptides are synergistically active or that a dual mode of 
action with both peptides targeting different cellular structures leads to synergistic S. 
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aureus killing. Generally, such synergism of host- and commensal-peptides has 
rarely been reported: It has been shown that combination of the S. epidermidis Esp 
protease with hBD2 resulted in synergistic bactericidal activity that killed S. aureus in 
biofilms (Sugimoto et al., 2013). Moreover, the group of Richard Gallo recently 
demonstrated that AD patients are lacking bacteriocin-producing skin commensals 
and that re-establishment of bacteriocin-producing S. epidermidis and S. hominis 
prevents S. aureus from colonizing the skin of these patients. In this work they 
identified novel skin commensal-derived bacteriocins that act synergistically with LL-
37. Additionally, a single application of these bacteriocin-producing strains 
significantly reduced S. aureus loads on the forearms of AD patients already after 24 
hours indicating the great clinical potential of host and commensal peptide 
combinations (Nakatsuji et al., 2017). However, it is completely unknown whether 
other peptide antibiotics are equally well able to induce the expression of 
synergistically acting AMPs in skin as lugdunin. Considering their low cytotoxicity 
reported in Accepted Publication II, Figure S4 and their high antimicrobial potential, 
the synergistic peptide combinations described in this work might be ideal candidates 
for potential clinical applications in the topical treatment of S. aureus infection. 
7.2.7 Conclusion 
The results of this study show that lugdunin provides multi-level protection of the 
host against S. aureus (Figure 8). First, it can directly kill S. aureus and also act 
synergistically with the human AMPs DCD-1(L) and LL-37 in killing S. aureus. On a 
second level of protection, lugdunin amplifies the commensal-induced innate immune 
response in PHKs. And ultimately, lugdunin-induced recruitment of phagocytic cells 
might additionally contribute to effective eradication of S. aureus. It still has to be 
determined how lugdunin production is regulated and whether factors from the host 
side are able to induce lugdunin production by S. lugdunensis. Since applying 
bacteriocins or bacteriocin-producing bacteria onto the skin have already become 
valuable strategies for preventing S. aureus colonization (Nakatsuji et al., 2017), 
future therapies using the synergistic effect of AMPs and lugdunin as well as the 
lugdunin-induced enhancement of integral pathways of the cutaneous innate immune 
defense could be promising alternatives to simple antibiotic treatment. Especially the 
lack of resistance mechanisms of S. aureus against lugdunin demonstrates its high 
potential for clinical applications (Zipperer et al., 2016). And in the unlikely event of 
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resistance development, only its direct bactericidal effect is impaired, whereas its 
immune-modulating potential would remain unaffected. 
 
Figure 8: The different levels of lugdunin-mediated skin protection (Accepted Publication 
II, (Bitschar et al., 2019) 
Lugdunin acts on multiple levels to protect the skin against an S. aureus infection: Firstly, 
lugdunin directly inhibits and kills S. aureus. Secondly, it cooperates with host-derived AMPs such 
as hCAP18/LL-37 as well as DCD-1(L) to synergistically kill S. aureus. Ultimately, by inducing an 
innate immune response in the skin leading to the recruitment of phagocytic immune cells that 
potentially clear invading pathogens, lugdunin provides a third level of skin protection. 
Additionally, this innate immune response can be highly amplified by S. epidermidis-derived 
factors. 
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7.3 Staphylococcus aureus skin colonization is enhanced by the interaction 
of neutrophil extracellular traps with keratinocytes 
As previously shown in section 7.1 (Accepted Publication I (Burian et al., 2017)), 
S. epidermidis does not effectuate skin protection during skin inflammation. 
Additionally, it was previously demonstrated by our group that both S. aureus 
colonization and persistence on murine skin are significantly increased upon tape-
stripping (Wanke et al., 2013). Therefore, this work aimed at analyzing the 
mechanisms that lead to enhanced S. aureus colonization in an inflammatory 
environment. 
7.3.1 Skin inflammation induced by tape-stripping promotes S. aureus 
colonization in vivo 
At first, we reproduced the data that show that S. aureus skin colonization 
increases in an inflammatory environment (Wanke et al., 2013) by comparing the 
colonization efficiency of healthy and tape-stripped mouse skin. By using two 
different S. aureus strains, USA300 and SA113, we could confirm that S. aureus 
colonization is enhanced upon tape-stripping (Accepted Manuscript I, Figure 1a). 
Interestingly, both the MRSA strain USA300 and the non-virulent and agr-deficient 
SA113 strain showed enhanced colonization upon tape-stripping already indicating 
that the effect might be independent of virulence factors which are mainly controlled 
by the agr quorum sensing system (see section 5.2.3.1). 
Further analysis of the levels of pro-inflammatory cytokines in mouse skin 24 
hours after tape-stripping showed that levels of TNFα, GM-CSF and IL-6 were 
clearly, however not significantly, induced whereas reduced levels of IL-10 could be 
observed (Accepted Manuscript I, Figure 1b). Levels of IL-1α, MIP-2, MCP-1 and 
IFN-β were not altered substantially (Accepted Manuscript I, Figure S1a). These 
results confirm previous work from others and our group demonstrating that tape-
stripping leads to enhanced S. aureus colonization and persistence (Wanke et al., 
2013) as well as pro-inflammatory cytokine expression in mouse (Malhotra et al., 
2016; Onoue et al., 2009; Oyoshi et al., 2010; Wanke et al., 2013) and human skin 
(Dickel et al., 2010). Even though we could not detect changes in IL-1a levels, 
significant increases of IL-1a released from a pre-formed pool by keratinocytes in 
murine skin were reported within minutes upon tape-stripping indicating that IL-1a 
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might be an early orchestrator of skin inflammation upon tape-stripping (Wood et al., 
1996). 
In order to analyze whether an elevated pro-inflammatory environment induces 
enhanced S. aureus colonization, PHKs were treated with a cocktail of pro-
inflammatory cytokines containing 10 ng/mL IL-1α, TNFα, Oncostatin M, IL-22 and IL-
17A for 3 hours. This cytokine cocktail induced a massive pro-inflammatory response 
in PHKs resulting in strong expression of IL1A, IL1B, TNFA, CXCL8 and IL6 
(Accepted Manuscript I, Figure S1b), however, in our established adhesion and 
invasion assay (see section 7.1) these cytokines did not affect S. aureus colonization 
efficiency (Accepted Manuscript I, Figure 1c). These data led us to assume that 
enhanced S. aureus colonization upon tape-stripping is not a direct effect of elevated 
pro-inflammatory cytokines but that there are other factors present in vivo that 
contribute to S. aureus colonization. 
Therefore, we analyzed the composition of immune cell infiltrates in mouse skin 
24 hours after tape-stripping (Accepted Manuscript I, Figure 2 and Figure S2). We 
found that only percentages of neutrophils (live CD45+ CD11b+ Ly6G+ Ly6C+) and 
monocytes (live CD45+ CD11b+ Ly6C+) are significantly increased (Accepted 
Manuscript I, Figure 2a and Figure S2) upon tape-stripping, while percentages of 
overall CD45+ and other immune cell subsets are not significantly altered (Accepted 
Manuscript I, Figure S2). Further immunohistochemical staining for MPO-positive 
cells in mouse skin sections confirmed the enhanced recruitment of neutrophils 
(Accepted Manuscript I, Figure 2b). These results are in line with data observed by 
other groups who also show that tape-stripping induces early neutrophil recruitment 
within 1 day upon tape-stripping (Guiducci et al., 2010; Karisola et al., 2019; 
Takahashi et al., 2013). 
The enhanced S. aureus skin colonization observed in this study resembles the 
elevated prevalence of S. aureus in patients suffering from AD (Leyden et al., 1974; 
Totte et al., 2016). AD is a multi-factorial disease with many factors such as genetic 
or environmental influences contributing to its pathogenesis (Eyerich et al., 2015) 
(see section 5.1.1). However, until today the mechanisms that promote S. aureus 
colonization during the onset of the disease as well as the role of the neutrophils 
during this process are unclear. Choy et al. (2012) compared the transcriptomic 
profile of AD skin to healthy skin and found that genes encoding for neutrophil 
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chemoattractants such as CXCL1, CXCL2, CXCL8 and GM-CSF as well as the 
neutrophilic infiltrate in the dermis were significantly elevated in AD skin compared to 
healthy controls (Choy et al., 2012). In line with this, Dhingra et al. (2013) compared 
neutrophil-related genes in AD skin to healthy skin and also found that neutrophil-
related genes such as DEFB4A, CXCL8 and CXCL1 are significantly elevated in AD 
patients. Interestingly, they also associate higher neutrophil levels in AD with S. 
aureus infection (Dhingra et al., 2013). Taken together our data and the data 
presented in the above-mentioned literature suggest that an enhanced presence of 
neutrophils in the skin of AD patients contributes to the increased presence of S. 
aureus colonization and persistence on AD skin. 
7.3.2 Presence of neutrophils in the skin increases S. aureus colonization 
In order to test this hypothesis, we next investigated whether the presence of 
neutrophils in the skin contributes to elevated S. aureus colonization. Accordingly, we 
depleted neutrophils in C57BL/6 wild-type mice by injecting an anti-Ly6G antibody 24 
hours prior to skin colonization with S. aureus USA300 (Accepted Manuscript I, 
Figure 3a). Indeed, compared to the IgG isotype control group, neutrophil depletion 
resulted in a significant reduction of S. aureus skin colonization in most anti-Ly6G-
treated mice (Accepted Manuscript I, Figure 3b). These data clearly show that 
neutrophils contribute to enhanced S. aureus skin colonization. However, it should be 
noted that even though neutrophils were efficiently depleted, a small subgroup of 
mice inexplicably did not show reduced levels of S. aureus. 
Since neutrophil recruitment in response to S. aureus skin infection was shown to 
be dependent on IL-1β and the IL-1R1 (Miller and Modlin, 2007; Miller et al., 2006) 
we subsequently used IL-1R1-ko mice as a model for defective neutrophil 
recruitment. Indeed, upon S. aureus skin colonization IL-1R1-deficient mice fail to 
recruit neutrophils. Notably, compared to WT mice, IL-1R1-ko mice already displayed 
lower basal numbers of neutrophils during homeostasis (Accepted Manuscript I, 
Figure 3c). In line with the reduced S. aureus colonization observed upon neutrophil 
depletion, colonization of IL-1R1-ko mice was significantly lower compared to WT 
mice (Accepted Manuscript I, Figure 3d). 
On a first glance the fact that neutrophils contribute to enhanced S. aureus skin 
colonization may seem bizarre since neutrophil migration to infected tissues and 
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concomitant pathogen clearance is a fundamental component of innate immunity 
(Kennedy and DeLeo, 2009; Verdrengh and Tarkowski, 1997). Furthermore, it has 
previously been demonstrated by other groups that upon S. aureus skin infection 
recruitment of neutrophils is critical in infection resolution (Miller et al., 2006; Molne et 
al., 2000). Yet on a closer look, these data rely on subcutaneous or intradermal S. 
aureus injection models. But in a physiological setting, keratinocytes are the first cells 
to encounter S. aureus and they need to orchestrate subsequent chemokine and 
cytokine production to recruit neutrophils to the site of infection (see Accepted 
Publication III, (Bitschar et al., 2017)). In fact, in a recent publication, Liu et al. 
compared epicutaneous to intradermal S. aureus infection and the results show that 
critical players involved in bacterial clearance such as MyD88 have adverse effects 
when S. aureus is applied epicutaneously (Liu et al., 2017). 
In order to argue against objections, we decided to confirm the neutrophil-
mediated elevation of S. aureus skin colonization by establishing an in vitro co-
culture assay: In the co-culture model PHKs were cultivated in 0.4 µm cell culture 
inserts and primary polymorphonuclear cells (PMNs) or peripheral blood 
mononuclear cells (PBMCs) were added to the bottom compartment for 18 hours. In 
the following, S. aureus was added to PHKs and the number of viable colonizing 
bacteria 1.5 hours after infection was determined (Accepted Manuscript I, Figure 4a). 
In line with our in vivo data we found that the presence of PMNs, but not PBMCs, 
significantly enhanced S. aureus adhesion to keratinocytes (Accepted Manuscript I, 
Figure 4b). This effect seems to be dependent on soluble factors since direct contact 
of PHKs and PMNs is prevented by the 0.4 µm insert. However, the effect could 
neither be observed when using PMN supernatant instead of living PMNs (Accepted 
Manuscript I, Figure S3b). Interestingly, pre-incubation of PMNs with PHKs is crucial 
since this effect could only be achieved upon PMN pre-incubation with PHKs and 
presence during the infection. Elevated S. aureus levels were not observed without 
pre-incubation or sole presence of PMNs during the 1.5 hours of infection (Accepted 
Manuscript I, Figure 4b and Figure S3a). In summary, these data suggest that 
soluble factors secreted by S. aureus-infected keratinocytes induce PMNs to produce 
factors that create a favoring environment for S. aureus. 
We further investigated whether the effect could also be achieved by the 
commensal S. epidermidis. However, neither in the in vitro co-culture assay nor in the 
in vivo model upon tape-stripping enhanced colonization of S. epidermidis was 
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observed (Accepted Manuscript I, Figure 4c+d) indicating that the neutrophil-
mediated enhancement of skin colonization is specific for S. aureus. In an attempt to 
identify the S. aureus-specific factors involved in neutrophil-mediated enhancement 
of S. aureus skin colonization we used the USA300 ΔagrΔsae double mutant 
(Munzenmayer et al., 2016), lacking virulence factors, and an USA300 Δlgt mutant, 
lacking lipopeptides, in our co-culture model. However, as already indicated by 
enhanced colonization with the agr-deficient strain SA113 upon tape-stripping 
(Accepted Manuscript I, Figure 1a), neither of these factors contributed to enhanced 
S. aureus colonization in vitro (Accepted Manuscript I, Figure 4e). This was further 
confirmed in vivo by the usage of mice deficient for MyD88, TLR2, and TLR9 which 
did not show higher levels of S. aureus colonization than WT mice upon tape-
stripping (Accepted Manuscript I, Figure 4f). 
To summarize, our data clearly demonstrate that presence of neutrophils in vivo 
and in vitro enhances S. aureus skin colonization. By contrast, Malhotra et al. (2016) 
show that neutrophil-depleted mice display a significant defect in clearing 
epicutaneous S. aureus from tape-stripped skin. However, in this work S. aureus was 
applied 24 hours after tape-stripping and S. aureus colonization was analyzed 5 days 
after colonization (Malhotra et al., 2016). Taken together our data and the data from 
Malhotra et al. (2016) it is possible that the initial contribution of neutrophils to S. 
aureus colonization represents a local safeguard mechanism that tolerates enhanced 
colonization but at the same time prevents spreading of S. aureus in order to provide 
the time needed until a full adaptive immune response has developed. However, to 
confirm this hypothesis, time kinetics of immune cell compositions in the skin as well 
as of local and systemic S. aureus levels are needed. 
7.3.3 Neutrophil extracellular traps are responsible for increased S. aureus 
skin colonization 
In the following, we wanted to identify the neutrophilic factors mediating enhanced 
S. aureus colonization. In order to identify the responsible factors, we treated the 
PMN compartment in the co-culture model with DNAseI, protease inhibitors, phorbol-
myristate-actetat (PMA), the calcium ionophore ionomycin or the formylated peptide 
N-formyl-met-leu-phe (fMLF) (Accepted Manuscript I, Figure S4). Interestingly, only 
DNAseI treatment prevented an increase in S. aureus colonization in the co-culture 
model, whereas the other compounds used did not alter S. aureus colonization of 
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PHKs (Accepted Manuscript I, Figure 5a and Figure S4a). Of note, in the absence of 
PMNs, treatment of only PHKs with the different compounds did not affect S. aureus 
colonization (Accepted Manuscript I, Figure S4a) suggesting that neutrophils release 
DNA that consequently drives enhanced S. aureus colonization. 
DNA can be released by neutrophils in the form of NETs in response to microbial 
infection including S. aureus. These NETs are large, extracellular web-like structures 
which are released in order to trap and kill microbes and consist of decondensed 
chromatin covered with AMPs (Branzk et al., 2014; Brinkmann et al., 2004; 
Papayannopoulos and Zychlinsky, 2009) (see section 5.1.3). Since DNAseI treatment 
reverted enhanced S. aureus colonization, we hypothesized that NETs might be 
responsible for the observed increase in colonization. Thus, we analyzed the 
presence of NETs in the co-culture system by SYTOXTM staining as well as by an 
anti-double-stranded DNA (dsDNA) ELISA (Accepted Manuscript I, Figure 5b+c). In 
the SYTOXTM assay PMA treatment of PMNs was used as a positive control and 
resulted in a strong release of DNA which could be reverted by DNAseI treatment 
(Accepted Manuscript I, Figure 5b). Indeed, we could observe DNA release by PMNs 
in our co-culture setting upon S. aureus infection of PHKs (Accepted Manuscript I, 
Figure 5b). These data were confirmed by the anti-dsDNA ELISA where S. aureus 
infection of PHKs in the co-culture system also resulted in a strong release of dsDNA 
which could be reverted by the addition of DNAseI (Accepted Manuscript I, Figure 
5c). 
Since many microorganisms such as S. aureus have evolved different 
mechanisms that allow them to survive and escape neutrophil-mediated 
phagocytosis (Guerra et al., 2017) it can be assumed that NETs constitute an 
alternative tool used by neutrophils to kill these virulent microorganisms. Consistent 
with this idea, extracellular DNA measured by SYTOXTM was only observed when 
PHKs were infected with S. aureus and not upon infection with the skin commensal 
S. epidermidis (Accepted Manuscript I, Figure 5b). Neither did tape-stripping increase 
S. epidermidis loads on mouse skin (Accepted Manuscript I, Figure 1a). In line with 
this, also other groups have demonstrated that virulent entero-pathogenic bacteria 
induce NET formation whereas non-virulent probiotic bacteria do not (Vong et al., 
2014). To further confirm this observation, we performed confocal laser scanning 
microscopy (LSM) of PMNs which were either infected with S. aureus or S. 
epidermidis or treated with PMA as a positive control. Staining for citrullinated histone 
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H3 (citH3) and MPO, two NET components (Neeli et al., 2008; Papayannopoulos et 
al., 2010), confirmed that S. aureus infection of neutrophils indeed results in NET 
formation whereas S. epidermidis is phagocytosed (Accepted Manuscript I, Figure 
5d). Furthermore, to ultimately prove that the extracellular DNA observed by 
SYTOXTM and dsDNA ELISA in the co-culture model equals NETs, we additionally 
performed confocal LSM of PMNs in the co-culture setting. Indeed, we found NET-
forming PMNs only upon S. aureus infection of PHKs and not upon infection with S. 
epidermidis (Accepted Manuscript I, Figure 5d). In order to provide final proof that 
NETs are responsible for increased S. aureus colonization of PHKs, we purified 
NETs from PMA-stimulated PMNs and co-cultured PHKs with these NETs instead of 
PMNs (Accepted Manuscript I, Figure 5e). Of note, purified NETs did not decrease 
PHK viability in the concentrations tested (Accepted Manuscript I, Figure 5f). Indeed, 
purified NETs increased S. aureus colonization of PHKs in a concentration-
dependent manner. This increase was comparable to the increase achieved by 
PMNs and could also be reverted by DNAseI treatment (Accepted Manuscript I, 
Figure 5e). To ultimately confirm that neutrophil-mediated NET release increases S. 
aureus colonization of PHKs, we additionally used two inhibitors, GSK484 and CI-
Amidine, both targeting protein arginine deiminase 4 (PAD4), a critical player in NET 
formation (Papayannopoulos, 2018). These compounds effectively inhibited the 
release of extracellular DNA measured by SYTOXTM (Accepted Manuscript I, Figure 
S4b) and in the co-culture setting these inhibitors effectively prevented enhanced S. 
aureus colonization (Accepted Manuscript I, Figure 5g) further confirming that NETs 
cause the enhanced S. aureus colonization. Moreover, addition of neutrophilic 
genomic DNA (gDNA) to the co-culture nicely demonstrated that the effect is specific 
for NETs and cannot be exerted by other forms of DNA (Accepted Manuscript I, 
Figure 5g). In conclusion, these data show that S. aureus infection of PHKs induces 
the release of NETs from PMNs which consequently results in enhanced PHK 
colonization with S. aureus. 
Our observation is supported by the findings of Yipp et al. (2012) who used 
spinning-disk confocal intravital microscopy to observe NET formation upon S. 
aureus skin infection. Disruption of these NETs by DNAseI treatment of mice, 
however, resulted in increased bacteremia but reduced S. aureus loads on the skin 
indicating that NETs may be important for containment and prevention of acute 
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bloodstream infections but that they seem counterproductive in skin infections (Yipp 
et al., 2012). 
The work presented here illustrates that even though NETs may locally contain S. 
aureus infections, they also cause pathology by increasing S. aureus colonization. Of 
note, NETs have already been shown to directly damage epithelial and endothelial 
cells (Saffarzadeh et al., 2012; Villanueva et al., 2011) indicating that NET formation 
and clearance needs to be tightly regulated to prevent host cell damage. In our 
setting, however, NETs did not directly affect PHK viability (Accepted Manuscript I, 
Figure 5f). Considerably, NETs have also been associated with different pathologies 
such as Pseudomonas aeruginosa infections in cystic fibrosis patients (Yoo et al., 
2014), systemic lupus erythematosus (Garcia-Romo et al., 2011) or rheumatoid 
arthritis (Khandpur et al., 2013). A role for NET formation in AD patients suffering 
from S. aureus infections, however, has not been established yet. Future studies 
should aim at elucidating the signaling pathways that drive NET formation in 
epicutaneous S. aureus infection as well as at identifying the pathways that NETs 
induce in PHKs in order to explain how S. aureus colonization is increased. 
Of note, it was shown that tape-stripping itself without S. aureus infection already 
enhances NET formation of neutrophils in the skin which might additionally contribute 
to the enhanced S. aureus colonization observed (Guiducci et al., 2010). Notably, 
NET formation was also reported to be carried out, even though to a minor extend, by 
other cell types such as monocytes (Webster et al., 2010), macrophages (Okubo et 
al., 2018) or mast cells (Abel et al., 2011; Naqvi et al., 2017; von Kockritz-Blickwede 
et al., 2008). In our study we also found a significant increase of monocytes and 
slightly elevated levels of macrophages in mouse skin 24 hours upon tape-stripping 
indicating that NET formation by other cell types, which were not investigated in more 
detail in this study, might additionally contribute to enhanced S. aureus colonization 
observed in vivo. 
Even though a role for S. aureus virulence factors was excluded in our 
experimental setting (Accepted Manuscript I, Figure 4e), virulence factors have been 
shown to contribute to NET formation and might thus play a role in a physiological 
setting: For example, low concentrations of PVL and LukGH have been shown to 
prime neutrophils and induce NET formation (Graves et al., 2012; Malachowa et al., 
2013; Pilsczek et al., 2010). Additionally, bacterial-derived products such as N-formyl 
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peptides or the phenol-soluble modulins (PSMs) produced by S. aureus have the 
demonstrated ability to directly recruit neutrophils, followed by activation and lysis 
(Wang et al., 2007). Furthermore, S. aureus-mediated NET degradation with its 
staphylococcal nuclease and additional triggering of macrophage apoptosis with its 
virulence factor adenosine synthase A which convert NETs to 2’deoxyadenosine 
(Thammavongsa et al., 2013) might also contribute to S. aureus colonization. The 
factors that contribute to enhanced colonization in our model, however, need to be 
elucidated by future studies. 
7.3.4 S. epidermidis prevents S. aureus-induced neutrophil recruitment 
As it is shown in Accepted Publication I, pretreatment of mouse skin with the 
commensal S. epidermidis or with its secreted factors confers protection against S. 
aureus colonization. Based on the findings that neutrophils contribute to S. aureus 
colonization, we hypothesized that S. epidermidis might also modulate neutrophil 
recruitment during this protective process. Therefore, we used an in vitro Boyden 
Chamber assay to analyze the migrative capacity of PMNs in response to 
supernatant of PHKs treated with S. aureus only or pretreated with S. epidermidis 
CM followed by S. aureus treatment. Indeed, while supernatant of PHKs treated with 
S. epidermidis or its secreted factors induced a lower and non-significant recruitment 
of PMNs in the Boyden Chamber migration assay compared to S. aureus-infected 
PHKs, pretreatment of PHKs with S. epidermidis CM significantly reduced the 
number of migrating PMNs induced by S. aureus infection (Accepted Manuscript I, 
Figure 6a). To confirm these results in vivo, we epicutaneously pretreated mouse 
skin with S. epidermidis or PBS as a control followed by S. aureus infection 24 hours 
later. The next day, the number of neutrophils in the skin of these mice was analyzed. 
Indeed, S. epidermidis CM significantly prevented the recruitment of neutrophils to 
the skin in response to S. aureus, indicating that the prevention of neutrophil 
recruitment also contributes to S. epidermidis-mediated S. aureus protection in vivo 
(Accepted Manuscript I, Figure 6b). Conclusively, these results illustrate that S. 
epidermidis modulates the release of neutrophil-recruiting cytokines and chemokines 
in mouse skin. In fact, the reduced neutrophil recruitment also correlated with a 
reduction in pro-inflammatory cytokines induced by S. aureus such as TNFα, IL-6, 
GM-CSF, IL-17A or IL-12p70 and others in mouse skin (Accepted Manuscript I, 
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Figure 6c). Other cytokines such as MCP-1, IL-10 and MIP-2 were not significantly 
changed by S. epidermidis pretreatment (Accepted Manuscript I, Figure S5). 
In summary, the results presented in this work might partially explain why S. 
epidermidis is able to protect the skin against S. aureus colonization (Accepted 
Publication I, (Burian et al., 2017)). However, whether S. epidermidis also interferes 
with NET formation capacities of neutrophils in mouse skin remains to be determined 
by future studies. Moreover, it remains elusive why S. epidermidis does not protect 
the skin during skin inflammation. Therefore, neutrophil recruitment in response to 
tape-stripping needs to be analyzed upon pretreatment with S. epidermidis. However, 
it was also shown that skin inflammation in the form of tape-stripping alters the 
composition of the microbiome (Karisola et al., 2019; Zeeuwen et al., 2012) which 
might be another factor to consider that might interfere with the commensal’s ability 
to modulate neutrophil recruitment. 
7.3.5 Conclusion 
Even though NETs are extruded from neutrophils in order to trap and kill 
microbes, this work intriguingly demonstrates that enhanced presence of neutrophils 
in murine skin or in a human in vitro co-culture system of keratinocytes and 
neutrophils and concomitant NET formation enhances the ability of S. aureus to 
colonize the skin. S. aureus seems to benefit from NET formation as it might 
generate a new microbial niche in inflamed areas of the epithelial barrier, which might 
be exploited for colonization. Another possibility to explain this phenomenon is that it 
might represent a host-initiated safeguard mechanism by which allowance to 
temporarily colonize the skin might provide the additional time needed to initiate an 
adaptive immune response. During this time the infection may be kept locally under 
control and systemic infections may become rather unlikely. Finally, we present a 
model (Figure 9) in which an alliance of keratinocytes and the skin microbiota 
collectively prevents S. aureus from colonizing the skin during homeostasis. 
However, upon colonization with S. aureus, due to skin inflammation or dysbiosis, 
neutrophils are being recruited and undergo NET formation which ultimately 
enhances S. aureus levels on the skin. Future studies are necessary to resolve the 
mechanistic details in this scenario. 
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Figure 9: Proposed model of the role of neutrophils during epicutaneous S. aureus skin 
colonization (Accepted Manuscript I) 
In healthy skin (left panel) concordant action of keratinocytes and the skin microbiota prevents S. 
aureus from colonizing the skin by reducing the recruitment of neutrophils. However, during skin 
inflammation or upon S. aureus colonization (right panel), neutrophils are recruited to the skin 
where they undergo NET formation resulting in enhanced S. aureus colonization of the skin. 
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7.4 Conclusive remarks and future perspectives 
Bacterial interference by commensals that leads to inhibition of S. aureus skin 
colonization is a multifactorial phenomenon that we are only beginning to understand. 
It is likely that several independent mechanisms overlay each other adding to the 
resistance to S. aureus colonization. The mechanisms described here, executed by 
two members of skin commensals, S. lugdunensis and S. epidermidis, can only partly 
explain the mechanisms that prevent S. aureus from colonizing. There are myriads of 
other commensal microbes that were attributed skin-governing effects and there 
might be a multitude of other peptide antibiotics produced by our own commensals 
that also target S. aureus as well as other pathogens. Additionally, the mechanisms 
described in this work seem to be context-dependent: While S. epidermidis 
significantly protects healthy skin from S. aureus, S. epidermidis seems to even 
contribute further to S. aureus colonization during skin inflammation. Moreover, this 
work illustrates that also the outcome of immune cell recruitment is context-
dependent and its consequences can be opposing: While lugdunin-induced 
neutrophil recruitment likely contributes to reduced S. aureus colonization, the 
presence of neutrophils upon tape-stripping as well as in our in vitro colonization 
model results in enhanced S. aureus colonization. For future studies it will be 
important to investigate how the ability of other skin commensals to produce 
antimicrobial molecules and modulate skin immunity contributes to S. aureus 
colonization resistance and whether the absence of such mechanisms may promote 
the development of AD.  
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Figure S1: Skin inflammation increases S. aureus skin colonization in 
vivo
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Figure S2: Gating strategy and quantification for immune cell analysis
in mouse skin
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a
Figure S3: In vitro co-culture with PMNs increases S. aureus
colonization of keratinocytes
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Figure S4: DNAseI treatment reduces S. aureus coloniza9on in PMN-
PHK co-culture
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Figure S5: Skin commensals modulate S. aureus-induced pro-
inflammatory cytokine release
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